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ABSTRACT
Embryo and Gamete Development upon Exposure to CCA
Components: CrC>3 , CuO, and AS2O 5
Nervana Talaat-Elsabaei Mahmoud
Old Dominion University, 2003
Director: Dr. R. James Swanson
Production o f functional gametes and healthy embryos is essential for proliferation
o f all vertebrates, especially humans. M any compounds have toxic effects on developing
gametes and embryos among which are chromium trioxide (C1O 3), cupric oxide (CuO)
and arsenic pentaoxide (AS2 O 5) as a mixture (CCA) or individually. Controversy
surrounding the safety o f CCA-treated wood centers primarily on the toxicity o f its
components and the potential for these metals to be released from the wood.
The aim o f this research is to test the hypothesis that CCA components have
deleterious effects on embryo development, oocyte maturation and integrity and sperm
function.
A two-cell embryo assay was proposed to detect embryotoxicity o f the CCA
components and their mixtures. Total blastocyst cell numbers, analyzed by fluorescent
DNA-binding, were the indicator o f embryotoxicity on the subcellular level. Oocytes, in
vitro-matured in the presence o f CCA components, were analyzed for cell cycle
progression. Spindle formation and chromosomal patterns in MI and M il oocytes were
analyzed by immunofluorescent staining. A sperm motility index was used to evaluate
sperm function in the presence o f CCA components. Sperm viability was analyzed using
fluorescent staining.
Summarizing our results, embryonic exposure to arsenic, chromium and copper
concentrations o f as little as 0.5 mg/L have a toxic effect on embryo quality represented
by significant reduction in total cell numbers without reduction in the embryonic

developmental stages. Increasing the concentration above 0.5 mg/L was accompanied by
a dose-dependant decrease in embryonic development in the form o f a drop in the number
o f morula/blastula stage embryos and elevation in fragmented/degenerated embryos. A
trace amount o f arsenic, chromium or copper inhibits oocyte maturation. The metal
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compounds delay cell-cycle progression and arrest oocytes in meiosis. Aberrant spindle
and chromosome misalignments were a common feature in most M I and M il treated
oocytes. The sperm motility index and viability showed a reduction in the presence o f
trace amount o f CCA components.
In conclusion, acute-chronic exposure to arsenic, chromium or copper compounds
may affect embryo and gamete development and quality on the cellular-subcellular
levels.
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CHAPTER I
INTRODUCTION

1.1 Chromated Copper Arsenate (CCA)
1.1.1

CCA Defined

Chromated Copper Arsenate (CCA) is a mixture o f metallic salts used as a wood
preservative. As the name suggests, this compound contains chromium, copper and
arsenic. These metals protect wood from decay due to the action o f microbes, fungi, and
wood-feeding insects. The arsenic (As) repels insects, the copper (Cu) kills fungi and the
chromium (Cr) fixes the copper and arsenic in the wood. Typical uses include treatment
o f fence posts, decking, playground equipment, and structural lumber used where it will
be in contact with concrete or the ground. CCA originated in 1938 and has been
manufactured in three formulations over the years, known as CCA-A, CCA-B and CCAC. Various mixtures o f salts can be used to make CCA; therefore, its precise molecular
composition may vary from one formulation to another. The original CCA (CCA-A) has
been used in the United State since 1938. However, most currently used formulations are
CCA Type C which is a mixture o f arsenic pentaoxide (34 percent), chromium trioxide
(47.5 percent), and cupric oxide (18.5 percent) (Fields, 2001).
CCA-C was first introduced in 1968 and has become commonly used because it is
more tightly retained by treated wood than the earlier types o f CCA (Cox, 1991). CCAC, the modem variant o f the formula, is the most widely used today. All three formulas
contain the same basic ingredients, just in different proportions. Although CCA was
developed in the 1930s, it was not until the 1970s that it gained widespread use with the
popularity o f decks, porches, boardwalks, shelters, fences, and the substitute o f wood for
metals in children’s playsets. For regions that have particular invasive wood eating
insects such as termites, CCA-treated wood is also used for framing residential and
commercial stmctures. In 1970, less than 1 million cubic meters (m3) o f CCA-treated

The model journal for this dissertation was Human Reproduction.
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wood was produced in the United States (U.S). By 1985 that number had increased to
about

8

million m 3 and by 1995 to 14 million m 3 (Fields, 2001). In the production o f this

wood, as much as 250 liters/ m 3 o f CCA solution is generally infused into the wood by
pressure treatment. Instead o f applying the chemical to the surface o f the wood, the
wood is submerged in a cylindrical tank containing the preservative. The tank is
subjected to high pressure to force the CCA into the cells o f the wood. This results in
final concentrations between 7.800 and 78.000 milligram per kilogram. Common brand
names o f CCA formulations are Osmose, Wolman, and Rentokil (Fields, 2001).
1.1.2

Safety of CCA

A considerable degree o f controversy has surrounded the safety o f CCA-treated
wood. This controversy has centered primarily on the toxicity o f arsenic and chromium
and the potential for these metals to be released from the wood. In 1986, the U.S.
Environmental Protection Agency (EPA) ruled that CCA pressure-treated wood is safe for
interior use, play structures, garden edging, and vegetable stakes (U.S. EPA, 1986). This
ruling was based on the tight, "irreversible" binding o f the metals to the wood fibers
(Dahlgren and Hartford, 1972). However, the metals can be made bioavailable under
certain conditions. In several documented circumstances, CCA-treated wood has
produced adverse health effects. Peters and colleagues reported that a family was
stricken with a variety o f illnesses, including bronchitis, pneumonia, gastrointestinal
disorders, and severe alopecia after extended burning o f CCA-treated wood for heating
purposes (Peters et al., 1986a). Peters and colleagues later reported that two workers
developed pulmonary, hematologic, and gastrointestinal symptoms after several days o f
construction o f picnic tables using freshly treated CCA lumber in which the metals were
inadequately fixed (Peters et al., 1986b).
Data regarding the actual kinetics o f release o f metals from CCA wood are limited in
the peer-reviewed literature, but it appears that several factors, including time,
temperature, and humidity contribute to fixation and thus the bioavailability o f metals in
CCA-treated wood (Gordon et al., 2001). In freshwater environments, minimal leaching
o f metals from the CCA wood occurs, but it increases under acidic conditions (Warner
and Solomon, 1990). In marine water environments, Weis and colleagues have
demonstrated that metals are present in the fine fraction o f sediments near CCA-treated
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bulkheads in estuaries (Weis and Weis, 1992). These metals were generally confined to
within one meter o f the bulkheads and resulted in a reduction in the nearby biotic
community.
Thus, irreversible binding o f the metals to the wood fibers after pressure treatment is
not a guarantee, even though it is essential to minimize the potential exposure o f wood
handlers to chromium, copper, and arsenic. A field study determined that there were
evidences that the CCA preservative could leach from wood. In this study the copper,
chromium and arsenic content in soils under decks built with CCA-treated wood was
measured. The decks ranged in age from 4 months to 15 years. A total o f 85 soil
samples were collected from under a total o f seven decks built with CCA pressure treated
lumber. Control soils were acquired at a minimum distance o f 5 meters from the decks.
The samples were analyzed for copper, chromium and arsenic content by atomic
spectroscopy. The average amounts o f Cu, Cr, and As in milligram per kilogram (mg/kg)
in soils under decks were found to be 75, 43, and 76 compared to 17, 20, and 4,
respectively, in control soils and the amount tended to increase with deck age (Stillwell,
1997).
1.1.3

CCA-Treated Wood Playground Equipment

Sensitive individuals will exhibit a different or enhanced response to hazardous
chemicals when compared to most persons exposed to the same level o f hazardous
chemicals in the environment. Reasons may include genetic makeup, age, health and
nutritional status, and exposures to other toxic substances. In general, the young with
immature and developing organs will be more vulnerable to toxic substances than healthy
adults.
Special concerns about exposure o f children to toxic chemicals have been prompted
by studies o f their exposure to CCA caused by playing on pressure-treated wood
playground equipment. Children are at particular risk from arsenic-treated wood due to
several reasons:
• They are more likely to come into direct contact with the surface.
• Their hands are often sweaty and sticky, which would increase arsenic rub off.
• They are more likely to ingest the arsenic by putting their hands in their mouths.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4
•

Children receive a higher dose relative to their size (Environmental Working Group,
EWG, and the Health Building Network, HBN, 2001).
According to a nationwide sampling overseen by the Environmental Working Group

and the Health Building Network, an area o f arsenic-treated wood about the size o f the
hand o f a four year child contains an average o f 2 0 times the amount o f arsenic allowed
in a

6

ounce glass o f water by the U.S. EPA. EPA proposed drinking water allows up to

10 micrograms (pg) o f arsenic per liter o f water (U.S. EPA, 2000). However, the average
surface contamination levels in an area about the size o f a single four years old handprint
was between 174 and 263 pg o f arsenic.
It is easy to see how a child playing on structures made o f pressure treated wood
could easily ingest more than EPA’s proposed safe daily dose. Exposures to these levels
mean that about one child at every grade school would be expected to develop cancer
later in life because o f routinely touching arsenic-treated wood on playgrounds and at
home (EWG and HBN, 2001).
A Canadian study on soil samples showed that arsenic concentrations at the base o f
playground equipment were from 1.8 to 23.5 times the concentration in soil 10 meters
away from the equipment. Using a cloth (250-500 cm2) to wipe the structures showed
that extractable arsenic was present on all

10

o f the play structures studied, in

concentrations ranging from 4.8 to 149.3 pg per wipe. The wipe samples were also
analyzed for chromium and copper. Concentrations o f chromium varied from 4.2 to
555.8 pg per wipe and concentrations o f copper varied from 5.0 to 132.2 pg per wipe.
The study concluded that inorganic arsenic and chromium are poisonous and
carcinogenic when absorbed in excessive amounts and that while small amounts may be
harmless, it would be best to avoid any unnecessary exposure to arsenic or chromium
(Riedel et al., 1991).
1.1.4

Restrictive CCA Legislation

On February 12, 2002, the EPA announced initiation o f a voluntary adoption
program by the industry to move consumer use o f treated lumber products away from a
variety o f pressure-treated wood that contains arsenic by December 31, 2003, in favor o f
new alternative wood preservatives. As o f January 1, 2004, the EPA will not allow CCA
products to be used to treat wood intended for any residential use. The EPA has not
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concluded that CCA-treated wood poses any unreasonable risk to the public or the
environment. Nevertheless, arsenic is a known human carcinogen, thus the agency
believes that any reduction in the levels o f potential exposure to arsenic is desirable (U.S.
EPA, 2002).
1.1.5

Environmental permanence of CCA

After December 31,2003, wood-processing plants will no longer be able to use CCA
to treat wood intended for use in decks, picnic tables, landscaping timbers, gazebos,
residential fencing, patios, walkways/boardwalks, and play structures. However, CCA
will still be found in wood treated prior to this date and still used in residential settings.
In addition, prior built structures containing CCA-treated wood will not be affected by
this action. Another important source o f CCA release occurs during the disposal process.
The dominant disposal method for CCA-treated lumber in the United States is landfill
burial. However, the sheer volume o f biomass involved would place a considerable
burden on the limited landfill capabilities. In addition, the waste decomposes with time,
and there are concerns about the toxic metals finding their way into the soil and ground
water. Incineration is a second disposal option, but burning CCA-treated wood in
conventional incinerators releases dangerous levels o f arsenic into the atmosphere. The
resultant ash also contains excessive levels o f hazardous waste copper and chromium,
which require expensive disposal procedures (Fields, 2001).
Even with 2002 the EPA legislation, the biohazard effects o f CCA and its
components will be a problem for years to come. We cannot completely get rid o f CCA
from the environment and its health hazards will remain a big concern. CCA will
continue to leach from the old wood that is still in service and be released from
uncontrolled methods o f disposal. Toxic effects will probably be seen for decades.

1.2 Arsenic, Chromium and Copper Content of CCA
As mentioned previously, the controversy about the safety o f CCA has centered
primarily on their metal components. Following is a brief overview o f toxicity, mode o f
action and health hazards for each component o f CCA:

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

6

1.2.1

Arsenic

Arsenic is the most notorious o f the chemicals contained in CCA. It is a metalloid
element, but when refined, arsenic is tasteless, odorless and colorless. The metalloid,
arsenic, is a common environmental contaminant, occurring in both organic complexes
and inorganic forms. Inorganic arsenic was found in two forms, the trivalent and the
pentavalent arsenic. Trivalent arsenic (arsenite) is substantially more toxic than the
pentavalent form (arsenate) (Machado et al., 1999).
M ode o f Action
Arsenic has been recognized as a human toxicant for over 2000 years. Tales o f the
middle ages denoted the element as an acute lethal poison to both humans and pests. An
indication o f arsenic’s broad-spectrum toxicity is the use o f arsenic-containing
compounds as insecticides, rodenticides, herbicides, and plant growth regulator (WHO,
1981).
Several studies tried to explain the mechanism o f arsenic toxicity to living
organisms. Exposure to relatively low concentrations o f inorganic arsenic has recently
been shown to have a dramatic effect on the organization o f cytoskeletal elements in
cultured cells (Li and Chou, 1992). Inorganic arsenic impairs assembly and disassembly
o f microtubules, presumably by binding to protein sulphydryl groups, and thus interfering
with the mitotic spindle formation and cell division (Leonard and Lauwerys, 1980).
Arsenicals further cause chromosomal aberrations, which disrupt cell cycling, thereby
reducing the organism’s capacity for cellular proliferation (Jha et al., 1992).
The cytotoxicity o f arsenic depends to a lesser extent on the form o f arsenic. For
example, the cytotoxicity o f arsenic trioxide is due to its ability to form cyclic adducts
with sulphhydryl groups o f certain enzymes, resulting in abrupt inhibition o f glycolysis
and beta oxidation (Muckter et al., 1993). The substitution o f pentavalent arsenic for
phosphorus in mitochondria uncouples oxidative phosphorylation (Webb, 1966). At low
doses, the metabolic effects o f either form may be selectively detrimental to the
developing embryo and fetus. The cytotoxicity o f arsenic is also a consequence o f the
oxyanions affinity for sulphhydryl groups o f histones and nucleic acids, a reaction that
may be responsible for inducing the chromosomal damage in both in vitro and in vivo
arsenic-exposed cells (Jha et al., 1992). The chromosomal aberrations observed in fetal
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cells particularly following maternal arsenic exposure suggest that this latter mechanism
may be involved in the teratogenicity o f the arsenic (Nagymajtenyi et al., 1985). Arsenic
may generate reactive oxygen species to exert its toxicity, which is implicated in DNA
damage, signal transduction and apoptosis. Arsenic also inhibits in vitro cellular DNA
repairing enzymes (Li and Rossman, 1989), reduces cytosolic glutathione levels and
induces membrane lipid peroxidation (Huang and Lee, 1996), suggesting multiple
mechanisms may be involved in arsenic induced cytotoxicity, fetotoxicity and
teratogenicity. Arsenic is detoxified by hepatic methylation to organic arsenicals (Buchet
and Lauwerys, 1987) and the cofactor, s-adenylmethionine (SAM), is considered the
fundamental methyl donor in this pathway. Methionine and protein deficiencies are
thought to decrease availability o f this cofactor, and have been shown to result in
increased tissue retention o f inorganic arsenic in vivo (Vahter and Marafante, 1987).
Health Hazards o f Arsenic
Due to the untoward exposure o f several population groups around the world to
arsenic, the adverse health effects o f arsenic exposure are well known and well
documented. Following is some o f its common systemic effects (ATSDR, 2000a):
•

Toxicological Effect: Mild chronic arsenic poisoning can occur at doses as low as
0.15 mg per day. Serum arsenic level in the adult human normally ranges from 2-3
jLLg/1. The lethal dose o f arsenic for an adult human is between 1 and 2.5 mg/kg o f

body weight (Cox, 1991).
•

Dermatological Effect: Skin cancers in the form o f basal cell or squamous cell
carcinomas are one o f the most serious long-term dermatological health hazards from
continuous exposure to arsenic. Other serious dermatological hazards from chronic
arsenic exposure can include pre-cancerous actinic keratosis (AK) and darkening o f
the skin (hyperpigmentation) as well as hyperkeratosis o f the palms and soles o f the
feet have also been evidenced.

•

Respiratory Effect: Continuous arsenic exposure cause irritation and damage to the
mucus membranes in nasal passages and airways, including pharyngitis and rhinitis,
and can also exacerbate symptoms o f asthma. The greatest and most prevalent risk o f
prolonged arsenic exposure via inhalation is lung cancer (Li et al., 2002).
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•

Carcinogenic Effect: Chronic oral, dermal or inhalation arsenic exposure can lead to
several kinds o f cancer. The most common cancers are o f the skin, bladder, and lung;
the latter being most prevalent in cases o f inhalation exposure. Skin cancer can result
from dermal or oral exposure, and patients with arsenic-related skin cancer are more
prone to other internal cancers (Chen and Lin, 1994). Because o f the numerous and
extensive carcinogenic risks posed by arsenic exposure, the EPA has ranked it as a
Group A carcinogen (U.S. EPA, 2001). Group A carcinogens are considered known
human carcinogens. The carcinogenic effect o f arsenic may be through increasing
intracellular oxidant levels, promoting production o f mitogenic transcription factors
and antioxidant enzymes (Li et al., 2002).

•

Reproductive/Developmental Effect: There are serious concerns with arsenic
exposure and its potential to cause birth defects in both laboratory animals and
humans. A review o f the published scientific studies indicates that prenatal arsenic
exposure produced offspring with many different kinds o f malformations, including
cleft palate, limb, skeletal, ophthalmic, urogenital malformation with predominant
pattern o f fetal neural tube defects, specifically encephaloceles and exencephaly in
laboratory animals (Shalat et al., 1996). These results were true for several different
species o f laboratory animals, and the resultant malformations were dependent on
both dosage and timing. Arsenic is known to cross the placental barrier and
selectively accumulate in the fetal neuroepithelium during early embryogenesis
(Hanlon and Ferm, 1977). Arsenic is also listed as a known teratogen (Shephard,
1998). In one comprehensive study on arsenic’s potential for reproductive toxicity
the researchers concluded that arsenic should be considered as a probable human
reproductive toxin (Shalat et al., 1996). Furthermore, there have been concerns about
arsenic as an endocrine disruptor. Arsenic can cause intracellular effects by affecting
on the glucocorticoid receptors within the nucleus (Kaltreider et al., 2001).
The mechanistic role o f arsenic as a teratogen may be explained by different
theories. Inorganic arsenic may impair assembly and disassembly o f microtubules,
presumably by binding to protein sulphhydryl groups, and thus may interfere with
mitotic spindle formation and embryonal cell division (Leonard and Lauwerys, 1980).
Increased and unregulated cell death has been proposed as a mechanism o f arsenic
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induced teratogenesis (Mottet and Ferm, 1983). Teratogenesis was defined by the
Agency for Toxic Substance and Disease Registry U.S. public health service
(ATSDR, 1990) as structural defects that affect the development o f an organism.
Furthermore, arsenic has been shown in diverse in vitro studies to alter transcellular,
transcapillary and transplacental transport o f various nutrients (Dallaire and Beliveau,
1992), and in vivo to decrease the fetal zinc levels, possibly through induction o f
maternal metallothionein synthesis (Taubeneck et al., 1994). This latter effect may be
particularly significant in that low fetal zinc levels have been shown to be teratogenic
in humans (Cherry et al., 1981). Further, deficiencies o f select nutrients have been
proposed to enhance the teratogenic potential o f arsenic (Ferm and Hanlon, 1986).
A series o f studies (Nordstrom et al., 1978a; Nordstorm et al., 1978b; Nordstorm
et al., 1979) documented the reproductive hazards o f arsenic by examining women
who worked in a smelter in Sweden and were exposed to arsenic dust. These studies
showed that due to their exposure, their babies had a higher than expected incidence
o f congenital malformations, including lower than normal birth weights and
spontaneous abortions. Prolonged low dose human arsenic exposure has also been
associated with multiple adverse reproductive outcomes including spontaneous
abortion, stillbirth, developmental impairment and congenital malformation
(Aschengrau et al., 1989).
In 1997, the National Academy o f Science noted that humans might be even more
sensitive to the adverse reproductive effects o f arsenic than are the standard
laboratory species. This conclusion is likely derived from the fact that rodents are
more efficient methylators and more completely detoxify inorganic arsenates than
humans (Hughes et al., 1994). Moreover, it has been shown that humans are found to
be more sensitive to arsenic than most laboratory animals by a factor o f as much as
300 times. This heightened human sensitivity to arsenic's toxicity is thought to carry
over to teratogenesis (ATDSR, Toxicological profile for arsenic, 2000).
•

Mutagenic Effect: A mutation is a change in the genetic material in a body cell.
Mutations can lead to birth defects, miscarriages, or cancer. The effects o f arsenic on
genes read like a microcosm o f its effects on the entire body as a whole. The
deleterious effects o f arsenic include DNA damage and a wide variety o f genetic
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alterations, which can range from simple gene mutations (DNA base pair changes) to
grossly visible changes in chromosome structure or number. Some o f these changes
may cause genetic damage transmissible to subsequent generations. Moreover,
arsenic may cause genetic damage by interfering with the mechanism by which DNA
repairs itself (Morton and Dunnette, 1994).
1.2.2

Chromium

Chromium is a metal widely distributed as chromite at a concentration o f 250 pg/kg
soil. Plants contain between 100-500 pg/kg chromium and foodstuffs contain between 20
and 590 pg/kg. Chromium is an essential trace element for biological systems. Serum
chromium level in the adult human normally ranges from less than 0.05 up to 0.5 pg/ml.
In the U.S., the health-based guideline for a maximum water chromium concentration o f
0.1 mg/1 is enforced by the EPA (U.S. EPA, 1998).
Chromium exists in several forms, there is the benign trivalent (III) form that has
never been shown to cause any clinical problems and is an essential nutrient for humans
in amounts o f 50-200 pg per day. Trivalent chromium has been shown to be a cofactor
for a low molecular weight protein, which promotes the action o f insulin (Jeejeebhoy,
1999). On the other hand, there is the hexavalent chromium (VI) that has been classified
as a group A carcinogen (ATSRD, 2000b). Although the form o f chromium in CCA is
hexavalent, less attention is paid to the chromium in CCA because the treatment process
converts it to the more benign trivalent chromium. However, if during the pressure
treating process the hexavalent chromium is not fixed completely and converted to the
more benign trivalent form, it can leach out o f the wood in its original form even if
virtually all o f the chromium is fixed. The lethal oral dose o f hexavalent chromium for
adult human is 50 mg/kg o f body weight (Cox, 1991).
Mode o f Action
Hexavalent chromium is a strong oxidizing agent easily permeating biological
membranes. In the cell, hexavalent chromium is reduced to the trivalent form. During
the process o f reduction, reactive oxygen intermediates are formed and react with DNA.
This interaction with DNA is believed to mediate the genotoxic effects o f hexavalent
chromium (De Flora and Wetterhahn, 1989). In addition, hexavalent chromium
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penetrates the mitochondria and depresses oxygen consumption by inhibiting otketoglutarate dehydrogenase, an enzyme that supplies the respiratory complexes with
reduced nicotine adenine dinucleotide (Ryberg and Alexander, 1990).
Health Hazards o f Chromium
Arsenic often gets the most attention in any discussion o f the hazards o f CCA and
pressure-treated wood. However, the hazards o f leachable hexavalent chromium, known
to be present in CCA-treated wood at levels as high as 50% o f the total chromium, has
generally gone unmentioned (Nygren et al., 1992). Hexavalent chromium is as insidious
as its partner arsenic. It is also a known teratogen and group A carcinogen. Following
are some o f the health hazards related to chromium exposure (ATDSR, 2000b).
•

General Effects: High/moderate or chronic exposure leads to damage in nasal
passages, (including nasal septal perforation, nasal ulcers, nasal bleeding), lung
damage (with increased risk o f non-cancerous lung diseases), asthma attacks, skin
irritation, skin ulcers, and kidney problems such as renal proteinuria (ATDSR,

2000b).
•

Carcinogenic Effect: Exposure to chromium has been known to cause lung cancer
since the early 1930s. Based on extensive research on groups o f workers in the
chrome plating, tanning and welding industries, it is now known that exposure to
hexavalent chromium in the workplace increases the risk o f lung cancer in exposed
persons by a factor o f as much as 1500. The EPA has classified hexavalent
chromium as a Group A carcinogen (ATDSR, 2000b).

•

Reproductive/Developmental Effect: Numerous studies performed on laboratory
animals using hexavalent chromium demonstrated its teratogenic effects. Landmark
studies (Gale, 1978; Gale and Bunch, 1979) found that intravenously administered
hexavalent chromium is embryolethal and produces some teratogenic effects in
surviving hamster fetuses, including cleft palate and skeletal defects. These studies
also found that a dose o f 7.5 mg/kg o f chromium trioxide was able to produce cleft
palates in 85% o f the hamster fetuses. Other defects were also elicited including
exencephaly, micrognathia, and skeletal defects such as unossified vertebrae,
abnormal limbs, and internal defects. The cause may be related to the fact that
chromium delays the overall maturation o f some fetuses. Chromium trioxide has
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been demonstrated to be both embryolethal and teratogenic when administered
intravenously on the 8 th day o f gestation in hamsters (Iijima et al., 1979). Additional
studies (Junaid et al., 1996; Kanojia et al., 1996; Trivedi et al., 1989) have shown that
oral doses o f hexavalent chromium compounds cause malformations in laboratory
animals, including rats and mice. Pre-gestational exposure to hexavalent chromium
caused reproductive harm to the offspring o f exposed female rats. Rats were exposed
to doses o f 250, 500 and 750 ppm o f potassium dichromate for 20 days immediately
prior to fertilization. Chromium was detected in the blood, placenta, and fetuses o f
these test animals in proportion to the dosage they were given. Severe malformations
and birth defects were noted in the offspring o f all test animals. Reduced number o f
implantations, retarded fetal development, embryo- and feto-toxic effects including
reduced number o f fetuses (live and dead) per dam, and higher incidences o f
stillbirths and postimplantation loss were noticed in the 500 and 750 ppm-dosed
mothers. Therefore, exposure to hexavalent chromium compounds before gestation
causes birth defects in laboratory animals, probably due to the bioaccumulation o f
chromium in the mother and the fetus (Junaid et al., 1996). Moreover, the maternal
chromium is reported to pass freely through the placenta to the growing fetus as
evidenced from the analysis o f bones from 120 human embryos (Kanojia et al., 1996).
These findings clearly show the cause and effect relationship between exposure to
hexavalent chromium compounds and birth defects during the time proceeding
fertilization and the critical early phases o f fetal development. One can easily
extrapolate from these studies that periconceptual (prepregnant) and pregnant women
run a similar risk o f birth defects, if exposed to hexavalent chromium compounds,
such as those found in CCA-treated wood products, during this critical period o f fetal
development.
1.2.3

Copper

Copper is an essential nutrient and humans have a natural, efficient homeostatic
mechanism for regulating the body’s levels o f copper ions over a wide range o f dietary
intake. Copper also occurs naturally in all plants and animals and at high concentrations
in mussels and oysters. Copper is a heavy metal that is toxic in the unbound form.
Almost all o f the copper in the body is bound to proteins, thereby reducing the
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concentration o f unbound copper ions to almost zero (Arancibia et al, 2003). Most diets
contain enough copper (2-5 mg) to prevent deficiency and not enough to cause toxicity.
The World Health Organization suggests that 10-12 mg per day may be the upper safe
limit for consumption (ATDSR, 2002). In the U.S., the health-based guideline for a
maximum water copper concentration o f 1.3 mg/1 is enforced by the EPA.
Trace amounts o f copper are required in the synthesis o f hemoglobin and several
human enzymes (Cohen, 1979). Copper is an essential component o f a number o f
metalloenzymes involved in catalyzing oxidative metabolic reactions. The normal
human serum level is in the range o f 114 pg/dl (85-236 pg/dl) o f which 95% is carried by
the alpha-globulin copper oxidase ceruloplasmin. The remainder is bound to albumin or
amino acids. In the body, copper shifts between the cuprous (Cu+) and the cupric (Cu++)
forms, though the majority o f the body's copper is in the Cu++ form. The ability o f copper
to easily accept and donate electrons explains its important role in oxidation-reduction
reactions and the scavenging o f free radicals (ATDSR, 2002).

Mode o f Action
Copper, except in extremely high doses, is considered nontoxic to humans. Copper
is considered the least problematic metal in the CCA compound (Fields, 2001). The
incidence o f copper toxicosis in general population is remarkably low. However, chronic
copper toxicosis is likely to be o f greater concern and may result in death in extreme
cases. Copper poisoning can develop under certain conditions, depending on factors such
as genetic, age, diet and efficiency o f intestinal absorption and biliary secretion. M any o f
the toxicant effects o f copper are related to its oxidative damage to membranes or
macromolecules. As a metal active in oxidation-reduction, copper ions are able to
catalyze the formation o f hydroxyl radicals. The resulting oxyradicals have the potential
to damage cellular lipids, nucleic acids, proteins, and carbohydrates, resulting in wideranging impairment in cellular function and integrity. The exposure o f DNA to these
hydroxyl radicals in the presence o f copper results in oxidative damage to DNA. In
addition, the exposure o f DNA to hydrogen peroxide in the presence o f Cu (II) results in
oxidative damage to the DNA in the form o f strand breaks and base oxidation (Bremner,
1998).
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A common consequence o f copper induced production o f reactive oxygen species is
increased lipid peroxidation. This resulted in peroxidation o f mitochondrial membrane
lipids presented with changes in mitochondrial function in the form o f reducing cellular
charge, increasing mitochondrial leakage o f calcium into cytosol, or exposing the cell to
increased amounts o f superoxide generated by disruption o f normal electron flow
(Bremner, 1998). The toxicity o f copper at the cellular level is also due to its capacity to
inhibit sulfhydryl groups o f glutathione, cysteine, homocysteine, methionine, coenzymeA and pantetheine. Several important enzymes, i.e., glucose-6 -phosphate dehydrogenase,
glyceraldehyde-3-phosphate dehydrogenase and glutathione oxidase, are inhibited by
copper ions (Olivares and Uauy, 1996).

Health Hazards o f C o w er
•

General Effect: The adult human body burden o f copper is typically 80 to 150 mg.
If copper in excess o f this amount is ingested, it is excreted. If very large doses o f
copper are consumed and homeostatic mechanisms break down, signs o f acute
toxicity include vomiting, diarrhea, jaundice, anemia, and urinary problems will occur
(ATSDR, 2002).

•

Respiratory Effects: In humans, copper is a respiratory irritant. Factory workers
exposed to copper dust experienced mucosal irritation o f mouth, eyes, and nose
(Askergren and Mellgren, 1975; Suciu et al.,1981).

•

Hepatological Effect: A key feature o f the development o f copper toxicosis is the
hepatic accumulation o f copper and hepatotoxicty. Under normal circumstances,
much o f the copper in the liver occurs in the cytosol. With copper toxicity excess
copper accumulate in hepatic cell nucleus and lysosomes. Copper is an essential
component o f several important enzymes including superoxide dismutase, a free
radical scavenger and cytochrome-c oxidase involved in mitochondrial respiratory
metabolism as an electron transport protein (Rodrigues et al., 2003). Copper overload
impairs hepatic mitochondrial respiration, primarily through a decrease in cytochrome
c oxidase activity. DNA has also been reported to be a target o f metal-induced
damage in the liver, which may manifest as malignant transformation. Reduced
cellular ATP levels, lysosomal fragility, impaired cellular calcium homeostasis, and
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damage to DNA may all contribute to hepatocellular injury in copper overload.
Copper also exerts its effects by inhibiting the metabolic enzymes and by damaging
the subcellular membrane structures (Chvapil et al., 1972). It inhibits the Na+/K+pump leading to an increase o f [Na+]. As a consequence the operation mode o f the
Na+/ Ca2+- exchanger reverses and [Ca2+] rises (Benders et al., 1999). Moreover,
accumulation o f copper in hepatic nuclei destabilizes DNA (Bryan and Frieden, 1967)
and inhibits RNA polymerase activity (Novello and Stripe, 1969), manifested in liver
fibrosis and malignant transformation (Britton, 1996).
•

Reproductive/Development Effect: The reaction o f the mammalian embryo to
copper represents a biological enigma. On one hand, there is evidence that deficiency
o f copper during gestation is detrimental to embryonic survival in rat and chick
embryos. On the other hand, the presence o f small amounts o f excess copper in the
form o f an intrauterine device composed primarily o f metallic copper has a
detrimental effect on mammalian pre-embryonic development, preventing
implantation and blastocele development (Chang et al., 1970). Intravenous injection
o f copper salts into pregnant hamsters on the 8th day o f gestation caused an increase
in the embryonic resorption as well as the appearance o f developmental
malformations in surviving offspring. Malformations o f the heart appeared to be a
specific result o f copper toxicity (Ferm and Hanlon, 1974). Delayed growth and
development were observed in the offspring o f rats exposed to copper at 130
mg/kg/day in the form o f copper sulfate in their diet for 7 weeks prior to mating and
during gestation (Haddad et al., 1991). Sexual impotence was reported in 16% o f
examined factory workers exposed to copper dust (Suciu et al., 1981).

1.3 Health Hazards of Arsenic, Chromium and Copper Combined in CCA
The combination o f known toxins and carcinogens into a single chemical formula
may result in potent toxin, carcinogen and teratogen. CCA may present a greater acute
toxicity hazard than exposure o f the constituent compounds separately (Mason and
Edward, 1989). Exposures to CCA-treated wood components or to CCA-contaminated
environment actually represent combined exposures to the three metals, arsenic,
chromium, and copper. Biological effects associated with a co-exposure to a mixture o f
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metals are recognized to significantly differ from effects caused by an exposure to each
metal separately. The presence o f chromium and copper may affect toxicokinetics (e.g.,
absorption, tissue distribution/retention, biliary and urinary excretion) o f arsenic and vice
versa. As bulk chemical agents are used for the CCA treatment, other minor chemical
contaminants are also o f concern in their effect on the subsequent disposition o f arsenic
with co-ingestion by exposed children.
A study found that the acute toxicity o f CCA to daphniamagna and to a species o f
alga, Selenastrum capricortum, was greater than might be predicted from the toxicity o f
copper, although copper was the most toxic o f CCA’s three metals when the test
organisms were exposed to these metals individually (Solomon and Warner, 1989). This
suggests that the metals act jointly to cause toxicity. Additional experiments using the
metals in pairs indicated that copper and chromium have a synergistic toxic effect
(Mason and Edward, 1989). The same study found that combined acute exposure to
hexavalent chromium, arsenate, and copper causes a marked decrease in fetal weight,
increase in fetal resorption, and abnormal formation in rats, while none o f the metals is
teratogenic when administered in separate preparations intraperitonially. Co-exposures to
arsenic are known to cause a profound accumulation o f copper by the kidney cortex
(Ademuyiwa et al., 1996). Although, copper is a relatively nontoxic metal, possible
adverse consequences associated with its accumulation in the kidney should be
considered under these exposure conditions.
From the previous evidence, toxicological, teratogenic and reproductive hazard are
strongly implicating the arsenic and chromium elements o f CCA as the causative agents.
This could be due to the fact that arsenic and chromate cross the fetal placenta barrier in
pregnant women. The California Hazard Evaluation System and Information Service
(HESIS, 2001) have recommend that pregnant or nursing women minimize their
exposure to this compound. They even go on to state a similar point about men's
reproductive health.

1.4 Hazards of CCA and its Components on Embryos and Gametes
CCA compounds are found in many places in the child’s environment during the
most critical developmental period. The resulting long-term exposure may cause chronic
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toxicity within sensitive developing organs like those found in the reproductive system.
Both male and female gametes are very sensitive cells. Chronic toxicity could cause such
severe change that the damage to the germ cells could result in permanent decrease in
number or increase in abnormal morphology producing intractable infertility.
Reproductive Toxicity as defined by Agency for Toxic Substance and Disease
Registry U.S. public health service is the occurrence o f adverse effects on the
reproductive system that may result from exposure to a chemical. The toxicity may be
directed to the reproductive organs and/or the related endocrine system. The
manifestation o f such toxicity m ay be noted as alterations in sexual behavior, fertility,
pregnancy outcomes, or modifications in other functions that are dependent on the
integrity o f this system (ATSDR, 2002). CCA toxicity on the reproductive system may
be demonstrated as abnormality in the gametes in the form o f decrease in number or
increase in abnormal morphology and/or abnormality in embryonic and fetal
development.

1.5 Oocyte Maturation and Embryonic Development
Oocytes are long-lived postmitotic cells (Zamboni and Thompson, 1972). They are
formed during intrauterine life, and their number does not increase after birth. The
precursors o f oocytes, the primordial germ cells, originate from the endoderm o f the yolk
sac. These germ cells migrate to the presumptive gonads and convert to actively dividing
oogonia. Before birth, the cessation o f mitotic process and the initiation o f meiosis lead
to the formation o f the primary oocytes. Once formed, the primary oocyte persists in
prophase o f the first meiotic division until the time o f puberty. At puberty, one o f these
primary oocytes will grow every month until it becomes a fully-grown oocyte. Just prior
to ovulation, the fully-grown oocyte in the Graafian follicle resumes meiosis and
completes the first meiotic division ended by the emission o f the first polar body (PB).
Once the ovulation has occurred, the second meiotic division begins. It then stops at

metaphase II with chromosomes aligned on the metaphase II spindle (Knobil and D. Neil,
1993). At this time, the oocyte is called mature or metaphase II oocyte. Although the
exact cellular mechanisms responsorial for this meiotic arrest remain uncertain, it is
generally presumed that a granulosa cell-derived putative meiosis inhibitor is in play.
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This hypothesis is based on the observation that denuded (granulosa-free) oocytes are
capable o f spontaneously completing meiotic maturation in vitro. If sperm penetration
occurs, the mature metaphase II oocyte undergoes a second meiotic division, after which
the second polar body is eliminated. The resulted one-cell embryo will then undergo a
rapid mitotic division passing in the following preimplantation stages: two-cell embryo,
four-cell embryo, eight-cell embryo, morula then blastocyst (Knobil and D. Neil, 1993).

1.6 Research Techniques and Thesis Contributions
In this research, a number o f techniques will be used. For each o f these techniques,
we present a brief overview o f their previous usage and our contribution to use them in
this proposed study. Mouse embryos and gametes were chosen as the animal model in
this work because o f their high genetic similarity to humans. In addition, their sensitivity
to identify the toxicological effect and dose o f many chemicals that proved to cause
malformation, congenital defects and carcinogenic in human was approved in many
reproductive studies (Ackerman et al.,1984; Eichenlaub-Ritter and Boll, 1989).
1.6.1

Mouse Embryo Assay

Two-cell mouse embryo assay was initiated in our embryonic laboratory since 1980
as a quality control screening assay for media, supplements, cultureware, and related
equipment used in developing human In Vitro Fertilization (IVF) program for Jones
Institute in Norfolk, Virginia (Ackerman et al., 1984). Culture o f two-cell mouse
embryos to the blastocyst stage has been the most commonly used quality control
standard for human IVF (Dandekar and Glass, 1990). Two-cell embryos collected from
fallopian tube o f hormonally stimulated mice were able to detect a toxin in the cultured
media in an exposure dependant manner. Preimplantation embryo culture models
provided insights into the vulnerability o f reproduction to metal toxicities (Hanna et al.,
1997).
1.6.2

Embryo Quality

Following fertilization, the embryo, enclosed in an acellular envelope o f the zona
pellucida, undergoes a number o f cleavage divisions ending with blastocyst formation
(Hardy et al., 1989). Blastulation is a morphogenetic event in early embryonic
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development common to all mammalian species (De La Fuente and King, 1997). The
eutherian blastocyst is composed o f two distinct cell types: an outer epithelial layer o f
trophectoderm (TE) responsible for blastocoel fluid accumulation and specialized for
implantation, and an inner cell mass (ICM). Following the implantation, the TE only
gives rise to components o f placenta and extraembryonic membranes whereas the ICM
forms all three germ layers o f the fetus as well as the complementary contribution to the
extraembryonic membranes (Van Soom et al., 2001). Allocation o f cells to these two
primary lineages occurs at the preceding morula stage mainly during the fourth cleavage
division. Total cell number o f the blastocyst has been previously reported to be a good
indicator o f embryo quality and developmental rate. The total embryo cell numbers
appeared to be dependant on the culture medium used (Van Soom et al., 1997).
Therefore, the environment clearly plays a role during early embryonic development on
the number o f cells in an embryo (Knijn et al., 2003). Culture conditions affect
blastocyst formation rate (Viuff et al., 2001), reducing embryo quality by decreasing the
number o f embryonic cells allocated to the ICM, and by increasing the incidence o f
apoptosis in individual blastomeres (Brison and Schultz, 1997; Hardy, 1997). Nuclear
staining o f whole-mounted blastocysts for determination o f cell number has been
improved in efficiency and ease o f handling with the introduction o f chromatin-specific
fluorochromes (Thouas, 2001). Monochromatic staining methods using nuclear-specific
dyes have been used to stain for total blastocyst cell numbers and are still in use today
(Fong and Bongso, 1999). Fluorescent DNA-binding dye has provided a rapid and
accurate method for counting the number o f cells in the preimplantation mouse embryos
(Ebert et al., 1985).
To detect and compare the relative toxicities o f different concentrations o f tested
metal compounds (arsenic pentaoxide, chromium trioxide and cupric oxide) on embryo
development and quality, we examined both embryonic cell proliferation and
differentiation by analysis o f the rate o f blastocyst formation and embryonic cell numbers
at the end o f the culture period.
1.6.3

In Vitro Maturation of Oocytes

Oocyte maturation is defined as the reinitiating and completion o f the first meiotic
division, subsequent progression to metaphase II, and stimulating nuclear and
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cytoplasmic processes, which become essential for fertilization and early embryo
development. Oocytes are arrested in prophase I o f meiosis during the fetal period.
Completion o f the first meiotic division takes place when oocytes have undergone
extensive growth in cellular interaction with the granulosa and theca cells. The oocyte
undergoes asymmetric cytokinesis and extrudes the first polar body containing a haploid
chromosome complement. The first meiotic division is thus completed and the second
meiotic division is initiated, but oocytes remain arrested in metaphase II until contact is
made with a spermatozoon. The initiation o f maturation in fully-grown oocytes, which
are present in antral follicles, is based on the mid-cyclic onset o f the luteinizing hormone
(LH) surge or the exogenous administration o f human chorionic gonadotropin (hCG).
Mechanisms o f oocyte maturation in vivo and in vitro are still under investigation. In
vitro animal models provided insight into the importance o f substances affecting oocyte
maturation and its inhibition, such as cAMP, calcium, cell-cycle proteins, growth factors,
gonadotropin-releasing hormone (GnRH), gonadotropins, purines and steroids.
In vitro maturing mouse oocytes have been employed in many studies (EichenlaubRitter et al., 1986; Eichenlaub-Ritter et al., 1988a), to investigate factors affecting
oocytes developments during in vitro maturation to metaphase II. Mouse oocytes
isolated from large antral follicles o f ovary o f hormonally unstimulated animals
(Eichenlaub-Ritter and Boll, 1989) were cultured in absence or presence o f aneugens or
selected metabolites at defined concentrations. In this way, the threshold concentration
o f each element can be identified. Most importantly, these oocytes maturing in vitro
were processed for immunofluorescence to examine their spindle formation and
chromosomal behavior.
The differences in the mechanisms o f spindle formation and cell cycle control
during mitosis and meiosis and in the characteristic pattern and cell biochemistry o f germ
cells have an impact on the predisposition to errors in chromosome segregation in
response to certain drugs and chemicals. When germ cell chromosomes o f in vivo
exposed rodents to aneugens were analyzed cytogenetically, most o f them were
displaying non-disjunction, and meiotic delay (Eichenlaub-Ritter et al., 1988a). The
formation o f a functional spindle, completion o f the first meiotic division and high
fidelity o f chromosome segregation are essential features o f healthy oocytes (Eichenlaub-
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Ritter et al., 1986). Spindle morphology and chromosome alignments were used as one
indicator for the capacity o f the oocyte to form a chromosomally balanced embryo.
Chemicals such as chloral hydrate (Eichenlaub-Ritter and Betzendahl, 1995) were proved
to be toxic to the developing oocytes. Their toxic effect was through affecting on oocytes
meiotic maturation and fidelity o f chromosome segregation in mammalian oocytes
maturing in vitro.
Therefore, these techniques were used in this research to detect the toxicity o f
various concentrations o f the tested metal compounds on oocyte maturation and spindlechromosome behavior.
1.6.4

Sperm Motility Bioassay

The sperm motility bioassay was used in several studies and became an invaluable
quality-control test in some laboratories. This test has been used before and has showed a
greater sensitivity to embryotoxic factors (Bavister, 1974; Bavister and Andrews, 1988).
The degree o f sensitivity is greatly increased when protein or other chelating agents (e.g.,
amino acids) are excluded from the culture media (Esterhuizen et al., 1994). A sperm
motility index (SMI) o f spermatozoa obtained from the cauda epididymis o f adult male
(hamster or mouse) was the parameter used for comparison between the treated and
untreated sperm samples in all previous studies.
In this study, the sperm motility assay was used to detect the toxicity o f arsenic,
chromium and copper compounds on sperm function. Not only SMI was compared
between different tested compound concentrations, but also motility percentage and
forward progressive movement score were compared between samples.
1.6.5

Sperm Viability

One o f the most important parameters in the evaluation o f fertility is the analysis o f
sperm viability. The assessment o f sperm viability is one o f the basic elements o f semen
analysis and is particularly important in samples, where many sperm are immotile but not

dead, to distinguish between immotile dead sperm and immotile live sperm (Pintado et
al., 2000). Several methods have been used to distinguish between viable and non-viable
sperm cells, such as the nigrosin-eosin stain (Hancock, 1951) and fluorescent probes
(Gamer et al., 1986). Some would argue that these methods are unreliable because some

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22
sperm cells showed partial staining (eosin-nigrosin) or because the method may
overestimate the number o f non-viable spermatozoa (fluorescent probes). Fluorescent
staining with propidium iodide (PI) is a rapid and reliable assay for determining the
percentage o f live and dead spermatozoa in a semen sample (Huo et al., 2002).
Sperm viability in the presence o f tested compounds was analyzed, using fluorescent
staining with PI, to distinguish between immotile dead sperm and immotile live sperm
and to detect if the toxicity were through spermiostatic or spermicidal effect.

1.7 Specific Aims
Gamete and embryo deterioration in function and development with exposure to
toxic compounds is a significant problem. M any compounds and various materials have
been proven toxic to body systems specially the reproductive one. CCA mixture and its
individual components comprise four o f these potentially toxic compounds that many
studies have referred to their harmful effects on various body systems. No previous
studies have been found that investigated the hazardous effects o f the CCA compound
and its individual components on preimplantation embryos or gametes. The lack o f
contribution in this topic was our main motivation to investigate and study embryo and
gamete toxicity in the presence o f chromium trioxide (CrOa), cupric oxide (CuO) and
arsenic pentaoxide (AS2 O 5) components o f CCA.
To test the hypothesis that CCA components have detrimental effects on embryo
development, oocyte maturation and integrity and sperm function, three major aims were
designed to assess the validity o f this hypothesis:
Aim 1: To determine the effect o f CCA (single components, mixtures and
synergism-potentiation) on preimplantation embryo development (growth and
differentiation) at the cellular and subcellular level. Hypothesis: CCA components
reduce embryo development through deleterious effects on cell division and
differentiation.
Aim 2: To determine the developmental and genetic effect o f individual components
o f CCA on in vitro matured germinal vesicle (GV) oocytes. Hypothesis: CCA
components have toxic effects on cell cycle progression, spindle formation and
chromosomal alignment.
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Aim 3: To determine the effect o f CCA components on sperm function and viability.
Hypothesis: CCA components lead to sperm dysfunction and lethal changes.

In addition, the following items were identified:
•

The toxic concentration

(T C 5 0 )

for each tested metal component o f CCA for embryo

(T C 5 0 )

for each tested metal component o f CCA for oocyte

(T C 5 0 )

for each tested metal component o f CCA for sperm

development.
•

The toxic concentration
maturation.

•

The toxic concentration
function.
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CHAPTER II
MATERIALS AND METHODS

2.1 Experimental Design
Determining embryo and gamete toxicity from exposure to CCA and its components
provides the understanding critical for determining the risks in both acute and chronic
contact. This novel research protocol can test the toxicity o f any compound on embryos
and gametes and in this manner was used to evaluate the toxicity o f CCA and it’s
components. To test the hypothesis that CCA components have detrimental effects on
embryo development, oocyte maturation and sperm function, three major experimental
groups were employed:
•

Group A: Testing the toxicity o f individual components o f CCA and the co-mingled
CCA compound (mixed CCA; m-CCA) on embryos included three main experiments,
a brief description o f them follows:
Experiment 1: Toxicity o f individual components o f CCA
■ Testing the dose-dependent toxicity o f individual components o f the CCA
compound (chromium trioxide, cupric oxide and arsenic pentaoxide) on two-cell
mouse embryo development.
■ Determining the toxic concentration

(T C 5 0 )

and the effect o f each CCA

component on two-cell mouse embryo development.
Experiment 2: Toxicity o f the CCA compound
■ Detecting the toxicity-potentiating effects o f mixing the previously determined
nontoxic concentration o f individual components o f CCA on two-cell mouse
embryos.
Experiment 3: Embryo staining and total cell counting
■ Determining the total cell numbers o f blastocyst stage embryos cultured in the
nontoxic concentration o f individual components o f CCA.
•

Group B: Testing the toxicity o f individual components o f CCA on oocytes included
two main experiments:
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Experiment 1: Analysis o f cell cycle progression
■ Testing the dose-dependant toxicity o f individual components o f the CCA on
oocyte maturation.
■ Determining the toxic concentration (TC 50 ) and the effect o f each CCA
component on oocyte maturation.
Experiment 2: Cytogenetic analysis
■ Analyzing spindle morphology and chromosome behavior in the presence o f
individual components o f CCA.
•

Group C: Testing the toxicity o f individual components o f CCA on sperm included
two experiments:
Experiment 1: Sperm motility assay
■ Testing the dose-dependant toxicity o f individual components o f the CCA
compound on sperm.
■ Determining the toxic concentration (TC 50) and the effect o f each CCA
component on sperm motility
Experiment 2: Sperm viability
■ Monitoring the viability o f the sperm in the presence o f CCA components.

2.2 Animals
Animals used in this study were B6CBAF1/J female mice (Jackson Laboratory, Bar
Harbor, ME, USA) and CD1 male mice (Charles River Laboratories, Wilmington, MA,
USA). All animals used in this study were kept in the same environmental conditions, in
14-hr light/10-hr dark, temperature controlled (21-23°C) room. They were provided with
laboratory rodent chow and water ad libitum.
2.2.1

Justification of Animal Use

Mouse embryos and gametes were chosen as the animal model in this study for
several reasons:
•

Mouse embryo culture is sensitive to toxins (Ackerman et al., 1984).

•

Mouse embryo culture is commonly used to predict success for human IVF. Results
obtained will have a history o f application to human embryo and gamete function.
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•

Many reproductive studies have used the mouse model resulting in a large body o f
literature.

•

Superovulation is possible in the mouse model, allowing collection o f a large number
o f embryos and gametes per female mouse.
All experiments and animal procedures conform to the protocol approved by the

Institutional Animal Care and Use Committee (IACUC) (Assurance 98-040). Euthanasia
was by cervical dislocation, approved by the Panel o f Euthanasia o f American Veterinary
Medical Association.

2.3 Chemical Preparations
Chromium (Cr), copper (Cu), and arsenic (As) are used in this study as abbreviations
for chromium trioxide (Sigma, St. Louis, MO, USA), cupric oxide (Fluka, St. Louis, MO,
USA) and arsenic pentaoxide (Sigma). Stock solutions o f lOOx (100 mg/L water) arsenic
pentaoxide (AS2 O 5) and chromium trioxide (CrOa) were prepared and stored at room
temperature. The stock solution o f cupric oxide (CuO) at lOOx (100 mg/L water) resulted
in fine precipitations. Cupric oxide was completely dissolved by adding few drops o f 1
M HC1 and adjusting the pH o f the solution to 7.4 with 1M NaOH. The final
concentration o f lOOx stock solution o f cupric oxide was

86

mg/L.

2.4 Toxicity o f CCA Components and m-CCA on Embryos
2.4.1

Determining the Toxicity o f Individual CCA Components on Embryos

Two-cell mouse embryos were cultured in media containing different concentrations
o f each component o f CCA to create dose-response curve. The beginning concentration
for each component was 0.001 mg/L and was increased until 100% embryolethality was
achieved. Embryo development was analyzed at 48 and 72 hr o f culture.
Media Prevaration
Embryos were collected and cultured in modified Krebs bicarbonate-buffered
(mKBB) supplemented with 0.4% (4 mg/mL) bovine serum albumin (BSA fraction V;
Sigma). Medium was prepared, as described by Ackerman (Ackerman et al., 1983),
checked for a pH value between 7.6 and 7.8, filter sterilized through 0.22 pm filter unit
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(Nalge Co., Rochester, NY, USA) and refrigerated at 4°C. Culture medium beyond 4
weeks age was discarded. All media were pre-tested before use to prove their support o f
normal embryo development. Acceptable pre-tested cultured medium supported
development o f two-cell mouse embryos to the morula or blastocyst stage equal to or
greater than 75% after 72 hr culture (Ackerman et al., 1984).
Each experiment included a negative control group. Negative control embryos were
cultured in 0.4% BSA mKBB medium.
Superovulation and M atins
Female mice, 1-6 months old, were induced to superovulate by an intraperitoneal
(IP) injection with 0.1 mL (5 IU) pregnant mare serum gonadotropin (PMSG; Sigma;
2000 IU/ 40 mL phosphate-buffered saline (PBS) stored at -20°C in 1 mL aliquots)
followed 48 hr later by an IP injection o f 0.1 mL (5 IU) human chorionic gonadotropin
(hCG; Sigma; 5000 IU/100 mL PBS, stored at -20°C in 1 mL aliquots) (Hogan et al.,
1994). Immediately post-hCG injection, each female mouse was placed in an individual
cage with one proven fertile male CD-I mouse. Approximately, 16 hr post-hCG
injection, female mice were inspected for a coitus positive vaginal mucous plug.
Embryo Collection
Plug-positive female mice were sequentially euthanized by cervical dislocation
approximately 42 hr post-hCG injection. The abdominal wall was aseptically opened and
oviducts were excised and placed into 2 mL equilibrated mKBB culture medium in sterile
35-mm polystyrene Nunclon culture dish (Thomas Scientific, Swedesboro, NJ, USA).
Using a Zeiss dissecting microscope (Eastern Microscope Co., Raleigh, NC, USA), two
cell embryos were irrigated from the oviducts with a 30-gauge needle inserted into the
fimbriated end and connected to 1-mL tuberculin syringe (B-D Becton Dickinson,
Lincoln Park, NY, USA) filled with mKBB medium (Swanson and Leavitt, 1992). Only
morphologically normal two-cell embryos, as judged by oval, bilateral symmetry o f two
blastomeres with narrow perivitelline space and presence o f two small polar bodies were
harvested in 10 p\ aliquots and aseptically dispensed into various cultures.
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Embryo Culture
Individual two-cell embryos were cultured in per well in a 96-well Falcon culture
plate (B-D). Each well contained a final volume o f 200 pL including equilibrated
(minimum 30 minutes) 0.4% BSA mKBB medium plus the desired concentration o f the
test compound Cr0 3 , CuO or AS2 O 5 . Each compound was tested in sequentially
increasing freshly prepared concentrations with two or more replications separately for at
least 2 experiments. In each experiment, different concentrations o f each compound were
added to 0.4% BSA mKBB culture medium shortly before use. Media equilibration were
then took place for at least 30 min before each experiment. Embryos were cultured at
37°C in 5% CO 2 in 100% humidified air for 72 hr.
Embryo Monitoring and Analysis
Embryos were morphologically evaluated at 48 and 72 hr o f culture using an
Olympus inverted microscope (Olympus, America Inc., Melville, NY, USA) fitted with
an OLRC unit (Olympus Relief Contrast). Images were taken with a Qlmaging digital
camera (Quantitative Imaging Co., Burnaby, British Columbia, Canada) using Q Capture
2

software version 1 . 1 .
Developing embryos were categorized as 2-cell, 3-4 cell,

6 -8

cell, morula, blastocyst,

degenerated (condensed and granulated blastomeres), or fragmented (numerous and
uneven-sized blastomeres or cytoplasmic blebs).
Defining Embryotoxicitv o f CCA Components
For each test compound, the following parameters were defined relative to dose and
toxic effect on embryo development:
•

Toxic Concentration (TC 50 ): The concentration that inhibits 50% o f embryo
development to both morula and blastocyst stages at 48 and 72 hr o f culture
respectively when compared with the negative control group.

•

Nontoxic Concentration: The highest concentration o f compound exhibiting no
statistical difference on embryo development when compared with the negative
control.
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•

Subtoxic Concentration: The concentration at which embryonic development
exhibiting slight insignificant reduction when compared with the negative control
group.

Statistical Analysis
As a nonparametric equivalent to one-way analysis o f variance (ANOVA), the
Kruskal-Wallis ANOVA test was performed within each experiment to determine
significant differences among the treated groups. Treated groups were compared with
each other and with the control group using the Mann-Whitney test with Bonferroni
adjustment, a nonparametric equivalent to an independent t-test, for pair-wise multiple
comparisons. Comparing the number (percentage) o f embryo development in different
embryonic stage was performed using Chi-Square test.
2.4.2

Determining the Toxicity of the m-CCA on Embryos

Toxic and nontoxic concentrations o f Cr, Cu and As were estimated from the
previous experiment. To detect synergistic embryotoxic effects o f mixing the three CCA
components, nontoxic-subtoxic concentrations were chosen for each one and diluted with
mKBB culture media for the experimental m-CCA solution.
Five serial dilutions o f m-CCA compounds were prepared, each was containing
different nontoxic-subtoxic concentrations o f the individual CCA components.
•

CCA1 contained 1.7 mg/L chromium, 6.08 mg/L copper and 0.3 mg/L arsenic in a
final volume o f 8 mL medium.

•

CCA2 (3/4 o f CCA1) contained 1.275 mg/L chromium, 4.56 mg/L copper and 0.225
mg/L arsenic in a final volume o f 8 mL medium

•

CCA3 (2/4 o f CCA1) contained 0.85 mg/L chromium, 3.04 mg/L copper and 0.15
mg/L arsenic in a final volume o f 8 mL medium.

•

CCA4 (1/4 o f CCA1) contained 0.425 mg/L chromium, 1.52 mg/L copper and 0.075
mg/L arsenic in a final volume o f 8 mL medium.

•

CCA5 (1/10 o f CCA1) contained 0.17 mg/L chromium, 0.608 mg/L copper and 0.03
mg/L arsenic in a final volume o f 8 mL medium.
Embryo collection, culture, monitoring and statistical analysis were performed as

described for the proceeding experiments.
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2.4.3 Embryo Staining and Total Cell Counting
To detect the quality o f the treated embryos, total cell numbers o f blastocyst stage
embryos were used as an indicator o f embryotoxicity on the subcellular level. In vivo
produced two-cell mouse embryos were cultured in the presence o f nontoxic
concentrations o f individual CCA compounds. The total cell numbers were determined
in embryos reaching blastocyst stage after 72 hr o f culture. The non embryo-toxic
concentration for each component o f CCA was determined from the previous
experiments. The nontoxic concentration for each o f the 3 compounds was surprisingly
the same at a value o f 0.5 mg/L.
Embryo Stainins
The staining protocol used in this study was a modification o f Thouas method
(Thouas, 2001), in which, Zona-intact (expanding, or partially hatched) blastocysts were
incubated in 500 pL o f solution 1 [BSA-HEPES buffered M2 medium (Hogan et al.,
1994) with 1% Triton X-100 (Sigma)] in 9-cavity Pyrex brand plate (Fisher, Pittsburgh,
PA, USA) for up to 10 s or until trophectoderm visibly shrank as monitored visually
under a Ziess dissecting stereomicroscope. The Triton X-100 treatment increases the
intensity o f fluorescence o f DNA-dye complex due to loss or clearing o f the cytoplasm
without disruption o f nuclear integrity. Blastocysts were then immediately transferred
into 500 pL o f solution 2 (fixative solution o f 100% ethanol with 25 pg/mL bisbenzimide
(Hoechst 33342; Sigma)) and stored at 4°C overnight in a humidified chamber. Hoechst
is a membrane-permeable, fluorescent DNA stain with low cytotoxicity that intercalates
with specific regions o f the DNA. On the second day, fixed and stained blastocysts were
transferred from solution 2 directly into 15 pL droplets o f glycerol (Sigma) on a glass
microscope slide. Blastocysts were gently flatted by applying slight pressure to a cover
slip. This compression allowed accurate determination o f the number o f cells in
comprising the blastocyst since all the nuclei could be observed in essentially a single
focal plane. Coverslips were sealed with nail varnish for preservation. Slides were
stored at 4°C and evaluated within 1 week o f preparation.
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Total Cell Count
Cell counting was performed directly from images obtained on a Nikon
epifluorescence-fluorescence microscope (Nikon, Melville, NY, USA) with excitation
filter UV 330-380. Photographs were taken by a Spot camera (Diagnostic Instruments,
Sterling Heights, MI, USA) using Spot software version 3.0.
Statistical Analysis
The total cell numbers for blastocysts were compared between treated groups and
control groups using one-way ANOVA.

2.5 Toxicity o f Individual Components o f CCA on Oocytes
To determine the effect o f each component o f CCA on oocyte development, in vitro
maturation o f germinal vesicle (GV) stage mouse oocytes was performed in the presence
o f different concentration o f each component o f CCA. Cell cycle progression and
cytogenetic analysis were used as sensitive indicators for oocyte toxicity on the cellular
and subcellular level. Each component o f the CCA compound was tested separately in 2
or more replicates.
2.5.1

Analysis of Cell Cycle Progression

Oocyte Isolation
Female mice were injected with 0.1 mL (5 IU) PMSG to stimulate follicular
development. At 46-48 hr post-injection, female mice were euthanized by cervical
dislocation. The abdomen was opened aseptically and ovaries with their fat pads were
dissected and transferred into 35-mm petri-dish (Thomas Scientific) with 3 mL o f pre
warmed M2 medium (Sigma). The fat pads were dissected away and ovaries were
transferred to another 35-mm petri-dish. Large antral follicles were punctured using a
30-gauge, Vi inch sterile needle attached to a 1 mL sterile syringe. Oocytes were stripped
o f the surrounding cumulus cells by gentile aspiration/expulsion through a glass hand
operated micropipette (internal diameter about 90 pm). Nude oocytes (without cumulus
cell layers) found prior to the stripping process were discarded. Oocyte stripping had to
be short and gentle to insure viable cells. Oocytes with a GV and a diameter o f 70-80 pm
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were collected and washed in freshly prepared Waymouth medium (Gibco, Grand Island,
NY, USA) supplemented with 5% freshly thawed fetal calf serum (FCS; Gibco).
Oocytes Culture
Each group o f ten oocytes was transferred to a 4-well Nunclon multidish containing
a final volume o f 1 mL preincubated 5% FCS-Waymouth medium plus the desired test
compound concentration. Oocytes were cultured for 16-17 hr at 37°C in 100%
humidified, 5% CO 2 / 95% air. Control oocytes cultured in 5% FCS-Waymouth medium
(untreated) were run with each experiment. Experimental and control oocytes were
always freed by lots, from the ovaries o f one to two mice during a period o f not more
than 20 min and were cultured in individual wells according to their collection time lots.
This time lot segregation ensured that development was synchronous in the population o f
oocytes analyzed in each individual experiment.
Cell Cycle Progression
Cell cycle progression was analyzed with a compound microscope 16-17 hr after in
vitro culture. Evaluation included the following progression o f the number o f oocytes
moving from least to greatest development. (1) oocytes meiotically incompetent or G 2
arrested with an intact germinal vesicle (GV), (2) oocytes having resumed maturation and
resolved their nucleus (germinal vesicle breakdown, GVBD, Mi-arrested) and (3) oocytes
having progressed to second meiosis after undergoing cytokinesis and extraction o f the
first polar body (PB, metaphase II, M il arrested). In vitro maturation was considered
normal when at least 65% o f oocytes in the control group extruded a first polar body
within 16 hr o f culture (Eichenlaub and Betzendahl, 1995).
Images for each oocyte maturation stage were taken by an Olympus inverted
microscope with a Qlmaging digital camera (Quantitative Imaging Corporation) using Q
Capture 2 software version 1.1.
Defining Oocyte Toxicity o f CCA Components
For each CCA component, the following parameters were defined relative to dose and
toxic effect and dose on oocyte in vitro maturation:
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•

Toxic Concentration (TC 50): The concentration that inhibits 50% o f GV oocytes from
maturing to the metaphase II stage after 16 hr o f culture when compared with the
control group.

•

Nontoxic Concentration: The highest concentration o f the compound exhibiting no
statistical difference on oocyte maturation when compared with the control group.

2.5.2

Cytogenetic Analysis

Exposed oocytes which had resumed maturation and undergone GVBD and had
either (1) failed to emit a polar body (MI) or (2) had emitted the first polar body (M il),
were used for indirect anti-tubulin immunofluorescence.
Preparation o f Slides for Immunofluorescence
A circle with a diameter o f about 1 cm was drawn on the upper surface on each
previously ethanol-cleaned, frosted slide (VWR International Inc., W est Chester, PA,
USA) using a Pap pen (Research Products International Co., Mount Prospect, IL, USA).
Slides were coated with poly-L-lysine (VWR), washed with distilled water and air-dried.
Preparation o f Oocytes for Immunofluorescence
Tubulin, actin and chromatin were stained and observed by immunostaining and
fluorescent microscopy (Eichenlaub-Ritter et al., 1988a; Soewarto et al., 1995). Ninecavity Pyrex brand plates were used through the staining steps. Oocytes with or without
PB were stained in separate wells. Denuded oocytes were fixed and extracted for 30 min
in a water bath at 37°C in 200 pL microtubule-stabilizing buffer (phosphate-buffered
saline, supplemented with 0.1 M PIPES, 5 mM MgC12, 0.5% Triton X-100, 2%
formaldehyde and 2.5 mM EGTA) which preserves microtubules and chromosomes
(Eichenlaub et al., 1986; Eichenlaub and boll, 1989; Soewarto et al., 1995). Oocytes
were washed extensively and blocked overnight in a moist chamber at 4°C in 200 pL
wash medium (Blocking solution; phosphate-buffered saline, supplemented with 0.02%
NaN 3 , 0.01% Triton X-100, 0.2% non-fat dry milk, 2% rabbit serum, 2% bovine serum
albumin and 0.1 M glycine; Liu and Keefe, 2002). Non-specific binding o f prim ary and
secondary antibodies was prevented by incubation in blocking solution containing 2%
rabbit serum before the experimental antibody incubation steps.
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To visualize the meiotic spindles, oocytes were washed in 200 pL PBS, then
incubated with 100 pL o f the primary antibody, mouse monoclonal anti-a-tubulin
antibody (1:150 PBS; Sigma) for 45-60 min in a 37°C water bath. Oocytes were then
incubated in 200 pL blocking solution for 1 hr followed by incubation in 100 pL o f the
secondary antibody, fluorescein isothiocyanate (FITC)-conjugated anti-mouse IgG (1:200
PBS; Sigma) in a 37°C water bath for 1 hr. After PBS washing, oocytes were incubated
in darkness for 15-20 min in 100 pL 4 ’-6-diamidino-2’-phenylindole (DAPI, 10 pg/mL
PBS; Sigma) for staining the chromosomes. Finally, oocytes were washed twice in PBS
then mounted onto a specially prepared slide. Twenty pL o f DABCO anti-fade medium
(1,4-diazobicyclo-octane, 4 mg/mL in 25% glycerol/PBS, pH 7.4; Sigma) solution was
used on each coverslip. Coverslips were sealed with nail varnish. Slides were stored at
4°C and visualized within 1 month o f preparation.
Immunofluorescent Microscovv
The cells were evaluated using a Nikon Eclipse E600 fluorescent microscope with an
epifluorescent attachment (Nikon) using a combination o f two filter sets, (1) DAPI filter
(BA 515) for chromosome visualization and (2) FITC filter (BA 420) for spindle
visualization. Images were taken by a Spot RT digital camera (Diagnostic instruments)
using Spot RT software version 3.2.
Analysis o f Spindle Morphology and Chromosome Alignment
For each immunostained oocyte, spindle shape and chromosome alignment were
examined. The number o f oocytes with normal or aberrant spindles and the number o f
oocytes with aligned or unaligned chromosomes were recorded for each treated and
control group.
Statistical Analysis
Cell cycle progression data and cytogenetic data were analyzed using a Chi-Square
test. The Chi-Square test was performed to determine whether there were significant
differences among the treated groups. The treated groups were then compared with the
control using the Chi-Square with Yates correction.
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2.6 Toxicity o f Individual Components o f CCA on Sperm
2.6.1

Sperm Motility Assay

Sperm Preparation
Spermatozoa were obtained from 3-6 month old CD1 proven fertile male mice. The
males were sacrificed by cervical dislocation. The peritoneal cavity was opened and the
cauda epididymis and vas deferens were removed into a 1000 pL drop o f Earl’s balanced
salt solution (EBSS; Sigma) covered with equilibrated embryo-tested mineral oil
(Sigma). The vas deferens was irrigated and the epididymis was multiply transected and
its contents were gently expelled. The sperm suspension was incubated for 10 min at
37°C in 100% humidified 5% CO 2 / 95% air to allow the sperm dispersion before
assessment (Summers et al., 1995). The primary suspension was evaluated before use.
Sperm concentration and motility were determined using a Makler™ chamber
(Diagnostic instruments). Sperm suspensions with a motility less than 70% were
rejected. Using a sterile tip fitted with an Eppendorf pipetter (Fisher), eighty-three pL o f
well-stirred homogenous primary sperm suspension was delivered to inseminate each
culture dish.
Preparation o f Culture Dishes for Assay
Polystyrene Nunclon 35-mm petri-dishes were used throughout the assay. EBSS
medium was equilibrated 30 min, oil was equilibrated one day before each experiment.
Serum, protein and amino acid-free EBSS medium was used to increase the sensitivity o f
the assay (Esterhuizen et al., 1994). On the day o f the experiment, culture dishes were
prepared, each containing 417 pL o f equilibrated media with the desired test compound
concentration covered with oil. The test dishes were inseminated with 83 pL o f the
primary sperm suspension (final sperm concentration, 1-2 x 106/mL) and incubated at
37°C in 100% humidified, 5% CO 2 / 95% air for 4 hr. Each treatment was in triplicate.
Sperm M otility Evaluation
After 4 hr o f incubation, dishes were removed from the incubator and sperm motility
was evaluated. Two parameters o f sperm motility were evaluated: (1) percentage o f
motile and (2) the quality o f sperm motility. The percentage o f motile sperm was
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estimated using a Makler™ chamber. The quality o f motility or forward progression
quality (FPQ) was assessed subjectively, using a standard scale (Bavister, 1974): 0-no
movement; 1-twitching with no forward progressive movement (fpm); 2-slow fpm; 3good purposeful fpm; 4-rapid fpm without activation and 5-hyperactivation. H alf scores
were also used when 50% o f the motile sperm showed different score from the remaining
50%. For calculating the final test scores, the two motility parameters were combined to
yield a sperm motility index (SMI):
SMI= percentage o f motile sperm • (FPQ)2.
D e fining Toxicity o f CCA Component on SM I
For each CCA component, the following parameters were defined relative to the dose
and the toxic effect on sperm motility:
•

Toxic Concentration (TC 50 ): The concentration that causes 50% reduction in SMI
after 4 hr incubation with CCA components compared with the control group.

•

Nontoxic Concentration: The highest concentration o f the compound exhibiting no
statistical difference on SMI when compared with the control group.

Statistical Analysis
For each group, the mean and standard deviation o f the SMI were calculated. The
mean o f the SMI for each treated group was compared with the control group and other
treated groups using ANOVA with Tukey’s procedure for multiple comparisons. To
know if the SMI significant difference between groups was due to difference in the
percentage o f motile sperm or FPQ score, these two parameters were analyzed and
compared for each group using AVOVA with Tukey’s procedure.
2.6.2

Sperm Viability

From the previous experiment, the lowest toxic concentration for each CCA
component on sperm was determined. The lowest toxic-tested-concentration for all o f
three compounds was 0.5 mg/L. Sperm preparation and incubation in the presence o f this
concentration (0.5 mg/L) were done as described above. After 4 hr incubation, 25 pL o f
each sperm sample was taken through the staining procedure.
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Sperm Staining
Aliquots o f the sperm suspensions were stained with propidium iodide (PI; Sigma) as
described in (Pintado et al., 2000). PI is a membrane-impermeable dye excluded from
viable cells but entering dead or dying cells. PI was used for identification o f dead cells.
PI stained the cell by binding to DNA through intercalating into nucleic acid bases. A
stock solution o f 20x PI (100 pg/mL water) was prepared and stored at -20°C. A volume
o f 47.5 pL o f sperm suspension was incubated with 2.5 pL o f lx (5 pg/mL) PI staining
solution at room temperature for 5 min in total darkness. To avoid spermatozoa sticking
to the glass and producing staining artifacts, 5 pL o f bovine serum albumin (100 mg/mL
EBSS) was added to the stained sperm suspension. Ten pL o f sperm suspension was
mounted on a microscopic slide, coversliped and sealed with nail varnish.
Fluorescent Microscopy
Spermatozoal slides were observed using an Olympus reflected fluorescent
microscope (Olympus) with a TRITC filter (BA 590). Slides were observed within 20
minute o f preparation to avoid staining artifacts which could result in overestimation o f
non-viable cells. Sperm were observed only in the central area o f the slide. Spermatozoa
found to be completely or partially stained were regarded as non-viable. Non-viable
spermatozoa showed a bright red-orange fluorescence when stained with PI. Images
were taken using an Olympus laser scanning microscope (Olympus) model FV-300
equipped with Fluoview software version 3.047a.
Assessment o f Sperm Viability
For each preparation, 100 spermatozoa were counted in four different fields. The
percentage o f viable cells was calculated from the following equation:
Percentage o f viable cells = unstained immotile live cells / total immotile cells (stained +
unstained).
Statistical Analysis
For each preparation, the percentage o f stained cells was transformed using arcsine
transformation to obtain a normal distribution. In all experiments, statistical analysis
between control and treated groups was determined using the student’s t test.
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CHAPTER III
RESULTS

3.1 Embryo Development and Quality
3.1.1

Embryo Development in the Presence o f Individual CCA Components and
their Mixture

Two-cell embryos collected from sexually mature female mice were cultured in vitro
in well-defined culture medium (mKBB supplemented with 0.4% BSA). Embryonic
development at 48 and 72 hr o f in vitro cultured was observed in presence and absence o f
different concentrations o f individual CCA components and their co-mingled CCA
compound (mixed CCA; m-CCA). Embryos in each developmental stage were assigned
a developmental score. The developmental embryonic scores ranged from -1 to 4. These
scores correspond to the following developmental stages: -1 for fragmented or
degenerated embryos; 0 for 2-cell embryos; 1 for 3-4 cell embryos; 2 for 5-8 cell
embryos; 3 for morula and 4 for blastula (blastocyst). Each CCA component (arsenic
pentaoxide, chromium trioxide and cupric oxide) was tested for its embryonic effect. The
tested compounds were run in different concentrations (treated groups). For each test
compound, embryo developmental scores o f control and treated groups were ranked. The
mean rank o f developmental scores for control and treated groups was calculated and
statistically analyzed using non-parametric statistics equivalent to one-way ANOVA
(Kruskal-Wallis test). To detect the embryonic developmental effect and the toxicity
threshold o f different concentrations o f the tested compound, the mean rank o f embryonic
development for each concentration was compared with the control as well as the other
concentrations. The more advanced the developmental stage, the higher the score. A
higher score produced higher mean rank which indicated better embryonic development.
Pairwise comparisons o f each concentration with control and with other treated
groups were performed by post-hoc multiple comparison tests (Mann-Whitney).
M ultiple comparisons usually require some adjustment o f the criterion for significance (P
< 0.05) in order to decrease type I error. The criterion for any pairwise comparison is:
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0.05 / [N (N -l)/2] where N is the number o f the groups known as Bonferroni adjustment.
To decrease the number o f multiple comparisons and increase the significance o f the
result, selected concentrations for each tested compound were chosen. Different
concentrations o f the tested compound were excluded and replaced by only one
concentration if their mean ranks were in the same range o f the chosen concentration with
no statistically significant difference between them.
Preimplantation embryos advanced into five distinct morphological development
stages: 2-cell, 3-4 cell, 5-8 cell, morula and blastocyst (Figure 1A-E). Embryos failing
development progressed to the ffagmented-degenerated stage (Figure IF). As a second
test o f embryo development and to localize and magnify the toxic effect o f each tested
compound, the six embryonic stages were regrouped into three combined stages at the 72
hr culture period. The first category (premorula stage) includes 2-cell, 3-4 cell and 5-8
cell embryos. The second category (morula-blastocyst stage) includes morula and
blastocysts embryos. The third category (fragmented-degenerated stage) includes
fragmented and degenerated embryos. The proportion (percentage) o f tested compoundtreated embryos in different development stages was recorded and compared with the
control group at 72 hr o f in vitro culture using the Chi-Square test. Generally, when two
cell mouse embryos were cultured in 0.4% BSA mKBB, the majority was competent to
develop and reached morula-blastocyst stage within 72 hr o f culture. Only a few,
possibly morphologically abnormal 2-cell embryos, were incompetent to completely
develop and remained in the premorula stage or progressed to the fragmented
degenerated stage.
Curve estimation (Cubic model) was used to explain the percentage o f variability in
embryo development as a function o f concentration for each tested compound (doseresponse curve). Best-fit curve (theoretical curve) represents the best curve that is able to
explain the behavior o f the observed curve (actual data) with regression coefficient (R ) =
1. The closer the R2 value to 1 the more powerful the theoretical curve explains the
behavior o f the observed curve. For each curve, the regression equation and the
regression coefficient were given at 48 and 72 hr.
Throughout the result section, results were considered statistically significant if P <
0.05 and highly significant if P < 0.0001. For multiple comparisons with Bonferroni
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adjustment, results were considered statistically significant if P < 0.05 / [N (N -l)/2] and
highly significant if P < 0.005 / [N (N -l)/2].

Figure 1. Development stage o f two-cell mouse embryo cultured in vitro. (A) 2-cell
embryo. (B) 4-cell embryo. (C) 8-cell embryo. (D) Morula. (E) Blastocyst. (F)
Fragmented embryo. Embryos were observed under Olympus relief contrast optics.
Embryonic Development in the Presence o f Arsenic
To detect the toxic effect o f arsenic on preimplantation embryos, mean rank o f
embryonic development for As-treated groups was assessed and compared with the
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control group at 48 and 72 hr o f culture. In the presence o f 0.5 mg/L or less o f arsenic in
culture medium, embryonic development did not appear to be significantly different
compared with the control group. In addition, no significant difference was found in
embryonic development among 0.1, 0.3 and 0.5 mg/L As (Table I). Increasing arsenic
concentration above 0.5 mg/L appeared to have a significant suppressing effect on
embryo development. Consequently, 0.5 mg/L As was considered as a cut point and 0.1
and 0.3 mg/L As concentrations were excluded from multiple comparisons and
represented by 0.5 mg/L As.

Table I. Analysis o f two-cell mouse embryo development at 48 and 72 hr o f culture in
the presence o f arsenic
Concentration
[mg/L]
Control
0.1
0.3
0.5
0.7
0.9
1.1
1.3
1.5

Embryo
number

30
30
30
30
30
30
30
30
30

Mean rank o f embryonic development
48 hr

72 hr

196.9
190.4
205.2
194.1a
139.1**’a
119.7**’b
88.6**’b,c
48.8**’c
36.7**

186.0
177.0
186.0
186.0d
136.5 **’d
136.5 **’e
100.5 “ ’ef
60.0 **’f
51.0

** Highly significantly different from control, P < 0.0001.
The same superscript within columns denotes significant difference, P < 0.05.

At 48 hr, embryonic development o f the control group had the highest value
compared with the treated groups. At 72 hr, both control and 0.5 As-treated groups
exhibited the highest mean rank o f embryonic development with no significant difference
(P — 1.00) between them (Table II). All the remaining As-treated groups showed
significant reduction in their embryonic development compared with the control group at
48 and 72 hr (P < 0.00024; Table II). This reduction highly increased with the increase
o f arsenic concentration in culture medium, reaching 2/3 o f the control value at 1.5 mg/L
arsenic concentration. Pairwise comparisons between different concentrations were
significantly different (P < 0.00024), indicating that the reduction o f embryo
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development had a concentration-dependant response to arsenic presence in the culture
medium (Table II).

Table II. Multiple comparisons o f embryonic development in the presence o f selected
arsenic concentrations at 48 and 72 hr
Concentration
[mg/L]
Control
0.5
0.7
0.9
1.1
1.3
1.5

Embryo
number

30
30
30
30
30
30
30

Mean rank of embryonic development
48 hr

72 hr

168.2
166.4a,b’c,d,e
125.3**’a’f’8’h
111 .8 **'b’i’j
84.0**’c’f’k’1

155.0
155.0 n’° ’p’q’r
116.5**’”’s,t
116.5**' 0,u’v
88.5**’p,w,x
57 0**’q’s’u’w’y
50.0**’r’l’v’x’y

47_4**. d, g, i , k,m
3 5 5 **,e,h,j,l,m

** Highly significantly different from control, P < 0.00024.
Pairs o f values compared together indicated by same superscript,
a - y pairwise comparisons are highly significantly different, P < 0.00024.

The high mean rank o f control and 0.5 As-treated group at 48 and 72 hr resulted from
the fact that 100% o f their embryos were in morula-blastocyst stage with high
development score (Table III). W ith increasing arsenic concentration in the culture
medium above 0.5 mg/L, the percentage o f embryos at morula-blastocyst stage declined
in concentration-dependant manner reaching 0% at 1.5 mg/L As concentration. At the
same time, the percentage o f fragmented-degenerated embryos increased reaching 100%
at 1.5 mg/L As concentration.
The pattern o f embryonic development in the presence o f arsenic (dose-response
curve) was compared at 48 and 72 hr (Figure 2). The theoretical curve (best-fit curve,
represented by a solid line) was able to explain the behavior o f the observed curve (actual
data points, represented by a dotted line) in 98% (R2) at 48 hr and 97% at 72 hr. Both 48
and 72 hr best-fit curves showed an obvious sharply declining trend in embryonic
development in the presence o f arsenic. This decline in embryonic development
increased with rising arsenic concentration in the culture medium reaching its maximum
at 1.5 mg/L As.
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Figure 2. Concentration-dependent response o f embryo development at 48 and 72 hr o f
culture in presence and absence o f arsenic. Dotted curves represent the actual data
points; continuous solid curves represent the best-fit curve. R2 represents the regression
coefficient.
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Arsenic TC 50 on embryo development was expected to be in the range o f 1.1 mg/L.
At 48 and 72 hr, the mean rank o f 1.1 mg/L As-treated embryos was about half the
control value (84 versus 168.2, 88.5 versus 155 respectively) (Table II). In addition, only
36.7% o f 1.1 mg/L As-treated embryos were able to reach the morula-blastocyst stage
while the remaining 63.3% were in the fragmented-degenerated stage (Table III). This
indicates that arsenic has an inhibitory toxic effect on embryo development and increases
embryo fatality.

Table III. Embryo development o f two-cell mouse embryo 72 hr post-arsenic treatment
Concentration
[mg/L]
Control
0.5
0.7
0.9
1.1
1.3
1.5

Embryo
number

30
30
30
30
30
30
30

Number (%) of embryo
Premorula

Morula-Blastocyst

0
0
0
0
0
0
0

30 (100)
30(100)
19 (63.3)**
19 (63.3)**
11 (36.7)’*
2 (6.7)**
0 (0 )

Fragmented-Degenerated
0 (0 )
0 ( 0)

11 (36.7)
11 (36.7)
19 (63.3)
28 (93.3)
30 (100)

**Highly significantly different from control, P < 0.0001.

Embryonic Development in the Presence o f Chromium
Embryo development o f two-cell mouse embryo at 48 and 72 hr in presence and
absence o f different concentrations o f chromium was tested (Table IV). To decrease the
number o f comparisons between the control and the treated groups and between the
treated groups with each other, all the tested Cr concentrations were divided into four
groups; 0.1-0.5 mg/L; 0.7-1.2 mg/L; 1.5-1.9 mg/L; and 2-3 mg/L group. W ithin each
group, significant difference in the mean rank was tested. If all values within the group
did not significantly differ, one value was chosen to represent the group. Therefore, 0.5;
1.2; 1.5; 1.9; 2.5; and 3 mg/L Cr were used for multiple comparisons (Table V).
The mean rank o f embryonic development o f the control was the highest at 48 hr
compared with the treated groups. At 72 hr, 0.5 mg/L Cr-treated group had higher value,
statistically insignificant (P = 0.437), compared with the control. Although embryonic
development showed a concentration-dependant decreasing pattern in respond to the
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presence o f chromium in the culture medium, only 2.5 and 3 mg/L showed significant
reduction in embryonic development compared with the control group (P < 0.0024 at 72
hr for 2.5 mg/L Cr; P < 0.0024 at 48 &72 hr for 3mg/L Cr; Table V).

T able IV. Analysis o f two-cell mouse embryo development at 48 and 72 hr o f culture
in the presence o f chromium
Concentration
[mg/L]
Control
0.1
0.2
0.3
0.5
0.7
0.9
1.1
1.2
1.5
1.7
1.9
2.0
2.5
3.0

Embryo
number

50
6
18
21
18
22
21
25
17
34
17
6
10
7
9

Mean rank of embryonic development
48 hr

72 hr

152.0
144.3
140.0
129.1
147.3
156.7
162.4
167.9a
138.5a
136.2a
121.9“
123.0a
58.3 b
56.2*’b
16.2*’b

150.1
153.7
159.1
143.6
163.9
163.1
164.9
167.3c
144.6c
126.9c
104.6c
83.8°
44.1
47.4*
21 .8 *

* Significantly different from control, P < 0.05.
The same superscript within columns denotes significant difference, P < 0.05.

Table V. Multiple comparisons o f embryonic development in the presence o f selected
chromium concentrations at 48 and 72 hr
Concentration

Embryo

[mg/L]
Control
0.5
1.2
1.5
1.9
2.5
3.0

50
18
17
34
6
7
9

Mean rank of embryonic development
48 hr

72 hr

77.9
76.1
71.8
71.0
64.8a
33.9
11.7*’a

78.3
85.5 b’c
76.1
68.0
47.0
28.1 *’b
14.8*’c

* Significantly different from control, P < 0.0024.
Pairs of values compared together indicated by same superscript,
a - c pairwise comparisons are highly significantly different, P < 0.00024.
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The number (percentage) o f embryos at different development stages at 72 hr o f
culture was analyzed (Table VI). Control group and 0.5 mg/L Cr-treated group have the
highest percentage (82%, 88.9% respectively) o f morula-blastocyst stage embryos
compared with other treated groups. Although, the percentage o f 0.5 mg/L Cr morulablastocyst stage embryos showed a higher value compared with the control group, no
significant difference was found between these two groups (P = 0.645; Table VI). In
addition, 80% o f control morula-blastocyst stage embryos were in blastocyst stage
compared with 77.8% for 0.5 mg/L Cr-treated embryos (Table A.4). Increasing
chromium concentration was accompanied by a drop in the number o f morula-blastocyst
stage embryos and an elevation in the number o f premorula arrested and fragmented
degenerated embryos. The presence o f 3 mg/L chromium in the culture medium caused
complete inhibition o f embryo development. At this concentration, none o f the cultured
two-cell embryos was able to reach the morula-blastocyst stage with 66.7% o f them were
in the fragmented-degenerated stage and the remaining 33.3% were arrested at the
premorula stage after 72 hr o f culture (Table VI).
To determine the development capability o f the Cr-treated premorula stage embryos,
embryos were cultured for an additional 24 hr (total 96 hr o f culture) and their
development was checked. Even after prolonged culture, premorula stage embryos failed
to develop to morula-blastocyst stage and all o f them became degenerated. This
indicated that even though some embryos were initially able to develop to premorula
stage in chromium presence; they were unable to complete their development normally
even with the extended culture and progressed to fragmented-degenerated stage.
From table V and VI, chromium TC 50 was determined to be around 1.9 mg/L Cr. At
this concentration, only 50% o f cultured embryos were able to reach morula-blastocyst
stage while the other 50% failed (33.3% were at premorula stage, 16.7% at fragmented
degenerated stage).
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Figure 3. Concentration-dependent response o f embryo development at 48 and 72 hr o f
culture in presence and absence o f chromium. Dotted curves represent the actual data
points; continuous solid curves represent the best-fit curve. R2 represents the regression
coefficient.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

48

Table VI. Embryo development o f two-cell mouse embryo 72 hr post-chromium
treatment
Concentration
[mg/L]
Control
0.5
1.2
1.5
1.9
2.5
3.0

Embryo
number

50
18
17
34
6
7
9

Number (%) of embryo
Premorula

Morula-Blastocyst

2 (4.0)
0 (0 )
3 (17.6)
9(26.5)**
2 (33.3)
4(57.1)**
3 (33.3)**

41 (82.0)
16 (88.9)
14 (82.4)
24 (70.6)
3 (50.0)
1 (14.3)**
0 (0 )

Fragmented-Degenerated
7 (14.0)
2 ( 11 . 1)
0 (0 )

1 (2.9)
1 (16.7)
2 (28.6)
6 (66.7)**

** Highly significantly different from control, P < 0.0001.

The behavioral pattern o f embryo development at 48 and 72 hr was analyzed using
curve estimation (Figure 3). At 48 hr, embryonic development showed slight reduction
in the presence o f chromium, this reduction became greater at 1.9 mg/L chromium
concentration reaching the lowest value at 3 mg/L Cr. At 72 hr, the behavior o f
embryonic development was slightly different. Embryonic development showed obvious
elevation (ascending limb o f the curve) at 0.5 mg/L Cr then gradually dropping
(descending limb), reaching their minimum value at 3 mg/L Cr. The theoretical curve
was able to explain 98%-99% o f the variability on embryonic development as a function
o f chromium concentration level at 48 and 72 hr o f culture respectively (Figure 3).
Embryonic Development in the Presence o f Copper
The presence o f copper in concentration up to 5 mg/L in embryo culture medium did
not show any detrimental effect on embryo development. The mean rank o f embryonic
development for these Cu-treated embryos at 48 and 72 hr was in the same range o f the
control value and even higher at certain concentrations (Table VII). Embryonic
development in the presence o f 1 mg/L and 5 mg/L copper concentrations were
significantly different (P < 0.05) from each other at 48 hr. However, at 72 hr no
significant difference was found between them. In addition, embryonic development at 5
mg/L Cu and 6 mg/L Cu did not show any significant difference at 48 and 72 hr.
Therefore, for multiple comparisons, 0.1, 1,5 and 6 mg/L copper concentrations were
represented by 1 and 5 mg/L Cu (Table VIII). Even though the presence o f 1 mg/L
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copper in the culture medium appeared to have a better effect on embryo development at
48 and 72 hr with higher mean rank compared with the control group, no significance
difference was found between these two groups (P = 0.161 at 48 hr; P = 0.571 at 72 hr).
Increasing copper concentration above 5 mg/L showed a significant suppressing effect on
embryo development, this suppressing effect reached it’s maximum with the presence o f
10 mg/L copper concentration in the culture medium (Table VIII).

Table V II. Analysis o f two-cell mouse embryo development at 48 and 72 hr o f culture
in the presence o f copper
Concentration
[mg/L]
Control
0.1
1.0

5.0
6.0
7.0
8.0
9.0
10.0

Embryo
number

28
11
16
30
20
22
19
21
10

Mean rank of embryonic development
48 hr

72 hr

128.9
147.7a
142.4a,b
108.1**’a,b
96.3**'a
61.5**
46.5**
33.6“
18.0“

122.6
124.0
126.2
124.5
114.8“
59.6**
35.5“
31.5“
31.5“

** Highly significantly different from control, P < 0.0001.
The same superscript within columns denotes significant difference, P < 0.05.

Pairwise comparisons o f embryonic development mean rank between groups were
significantly different indicating that the reduction in embryonic development has a
concentration-dependant response to copper’s presence in the culture medium (Table
VIII).
The percentage o f embryos reaching the morula-blastocyst stage in 1 mg/L or 5 mg/L
copper-treated groups was higher than the control group. However, no significant
difference was found between them (P = 0.235; P = 0.51 respectively; Table IX). In the
presence o f 7 mg/L copper in the culture medium, only 13.6% o f embryos were able to
reach the morula-blastocyst stage while 50% were still in the premorula stage and the
remaining 36.4% were in the fragmented-degenerated stage. All embryos cultured at 8 or
10 mg/L copper had completely failed to reach the morula-blastocyst stage with 89.5%
and 100% o f them were in the fragmented-degenerated stage respectively.
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Table VIII. Multiple comparisons o f embryonic development in the presence o f
selected copper concentrations at 48 and 72 hr
Concentration
r /T 1
[mg/L]

Embryo
number

Control

28
16
30
22
19
10

1.0
5.0
7.0
8.0
10.0

Mean rank of embryonic development
48 hr

72 hr

93.3
100.0 a’b’c’d

86.0

7 5 _f*,a,e,f,g

40.1**’b’e,h
28.9**’c,f’'
10.0 **’4 g’M

88.5 J’M
87 4 n-0
38.9**’j,m’p
22 . 1**'k'n'p
19.5** u

** Highly significantly different from control, P < 0.0003.
Pairs of values compared together indicated by same superscript.
a - p pairwise comparisons are highly significantly different, P < 0.0003.
g pairwise comparison is significantly different, P < 0.003.

Table IX. Embryo development o f two-cell mouse embryo 72 hr post-copper treatment
Concentration

Embryo

[mg/L]
Control
1.0

5.0
7.0
8.0
10.0

Number (%) of embryo
Premorula

28
16
30
22
19
10

0 (0 )

1 (6.3)
0 (0 )
11 (50.0)
2 (10.5)
0 (0 )

Morula-Blastocyst

Fragmented-Degenerated

26 (92.9)
15 (93.7)
29 (96.7)
3 (13.6)**
0 (0 )
0 (0 )

2(7.1)
0 (0 )
1 (3.3)
8 (36.4)**
17 (89.5)**
10 ( 100)**

** Highly significantly different from control, P < 0.0001.

There was no single copper concentration that fit exactly the TC 50 definition. In the
presence o f 5 mg/L Cu in the culture medium, significant reduction in embryonic
development was seen at 48 hr compared with the control. However, at 72 hr 5 mg/L Cutreated embryos did not show any significant difference in their embryonic development
or in the percentage o f morula-blastocyst embryos compared with the control group. At 7
mg/L Cu, a sudden toxic embryonic effect was obtained with great reduction in
embryonic mean rank, produced by decreasing morula-blastocyst embryo numbers and
increasing fragmented-degenerated numbers. Therefore, 6-7 mg/L Cu was considered as
the range for T C 5 0 .
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Figure 4. Concentration-dependent response o f embryo development at 48 and 72 hr o f
culture in presence and absence o f copper. Dotted curves represent the actual data points;
continuous solid curves represent the best-fit curve. R2 represents the regression
coefficient.
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The variability o f embryo development in the presence o f copper was analyzed at 48
and 72 hr. At 48 and 72 hr, embryonic development showed a rising trend (ascending
part of the curve) at 1 mg/L copper concentration. This trend changed to falling at 5-7
mg/L copper concentrations reaching the lowest value at 10 mg/L (Figure 4). The best fit
curve was able to explain almost all the embryonic behavior in the presence o f copper,
with R2 equals to 0.98 at 48 hr and 0.96 at 72 hr.
Embryonic Development in the Presence o f CCA Mixture
The results from the previous experiments helped to determine the nontoxic-subtoxic
concentration for each CCA component. The mixtures o f these concentrations (m-CCA)
were tested to detect their synergistic toxic effect on embryo development that result
from their presence together. Five mixtures were tested, m-CCAl represented the
mixture with the highest concentration while m-CCA5 was the one with the lowest
concentration (1/10 concentration o f m -CCA l). All m-CCA mixtures showed a
significant suppressing effect on embryo development compared with the control group
except m-CCA5. In the presence o f m-CCA5, there was no significant reduction in
embryonic development compared with the control group (Table X).
At 48 hr, m-CCA5-treated embryos showed a significantly higher rate o f embryonic
development than the control group. However, at 72 hr no statistically significant
difference was found between the m-CCA5 and the control group (P = 0.06). The
slightly lower rate o f the control group embryonic development compared with m-CCA5
was directly related to the slightly higher percentage o f the ffagmented-degenerated
embryos with negative scores in the control group compared to the m-CCA5. At 48 hr,
4% of control had fragmented-degenerated embryos versus 2.4% for m-CCA5. In
addition, 95.2% o f the m-CCA5 embryos were at the blastocyst stage resulting in a higher
development score while 0% embryos reached the blastocyst stage in the control group
(Table A.7). At 72 hr, 10% o f control embryos were in the fragmented-degenerated stage
versus 2.4% for the m-CCA5. Moreover, 97.6% o f m-CCA5 were in blastocyst stage
versus 90% for control (Table A.8). Most o f the m-CCA5 blastocysts were
morphologically abnormal and were characterized by one or more o f the following
features: unincorporated blastomeres, multiple cavities (possibly intracellular vacuoles),
no discrete ICM visible or low numbers o f mural TE cells.
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The m -CCAl group showed a significantly lower mean rank o f embryo development
compared with the control group. Moreover, the m -CCAl embryonic development mean
rank exhibited the lowest value compared with other treated groups. Diminishing mCCA1 embryonic development was due to increasing the number o f premorula and
fragmented-degenerated embryos (with low or negative score) and decreasing the number
o f morula-blastocyst stage embryos (with high score). By increasing the mixture
concentration, the number o f embryos reaching the morula-blastocyst stage was
significantly reduced in a concentration-dependant manner reaching 4.9% in the mCCA1. Correspondingly, the number o f premorula and fragmented-degenerated embryos
increased, reaching 12.2% and 82.9% respectively (Table XI) at m -C C A l. Pairwise
comparisons o f embryonic development mean rank between each m-CCA group were
significantly difference and decreased with increasing m-CCA concentrations. Clearly,
embryonic development has a clear concentration-dependant response to m-CCA
presence in the culture medium (Table X).
The variability in embryonic development in the presence o f CCA mixtures was
analyzed at 48 and 72 hr. At 48 hr, the presence o f low concentration o f CCA, CCA5,
did not show any significant toxic effect on embryo development. Increasing the CCA
concentration above CCA5 resulted in a step reduction in embryonic development until
the CCA2 value and then a slight elevation occurred at CCA1 (Figure 5). This elevation
o f CCA1 compared with CCA2 was directly correlated to higher percentage o f CCA1
premorula stage embryos were at the 8-cell stage compared with CCA2 (Table A.7).
At 72 hr the embryonic development pattern was similar to 48 hr. The rising lower
part o f the 72 hr curve resulted from a higher mean rank value for CCA1 and CCA2
verses CCA3. Lower mean rank o f CCA3 at 72 hr was resulted from 50% o f the
premorula stage embryos being in the 2-cell stage with a score o f zero (Table A.8). The
picture was different for CCA2 and CCA1. In CCA2, half o f the premorula stage
embryos were at the 4-cell stage and the remaining were in the 8-cell stage. In CCA1
premorula stage embryos, 70% o f them were at 4-cell stage and the remaining at 8-cell
stage (Table A.8). In addition, no significant difference was found between their
embryonic development mean rank (Table X).
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Table X. Multiple comparisons o f embryonic development in the presence o f CCA
mixture at 48 and 72 hr
Concentration

Mean rank of embryonic development

[mg/L]

48 hr

72 hr

Control
m-CCAl
m-CCA2
m-CCA3
m-CCA4
m-CCA5

197.1
110.4**’
65.4**- c’d’e
130.4**’c,f,g
169.7 a,d’f’h
280.9**’b,e’8,h

237.8
113.7**’’
115.9**’J
97.0” M
117.8** k m
251.51J’lm

The m-CCAi is a chromated copper arsenate mixture arranged from the highest to the lowest concentration.
** Highly significantly different from control, P < 0.0003.
Pairs o f values compared together indicated by same superscript,
a - m pairwise comparisons are highly significantly different, P < 0.0003.

Table XI. Embryo development o f two-cell mouse embryo 72 hr post-CCA treatment
Concentration
[mg/L]
Control
m-CCAl
m-CCA2
m-CCA3
m-CCA4
m-CCA5

Embryo
number

50
82
41
43
41
41

Number (%) o f Embryo
Premorula

Morula-Blastocyst

0 (0 )
1 0 ( 12 .2 )
6 (14.6)

45 (90.0)
4 (4.9)**
2(4.9)**
6 (14.0)*’
12 (29.3)**
40 (97.6)

4 (9.3)
1 (2.4)
0 (0 )

Fragmented-Degenerated
5 (10.0)
68 (82.9)**

33 (80.5)**
33 (76.7)**
28 (68.3)**
1 (2.4)

** Highly significant different from control, P < 0.0001.
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Figure 5. Concentration-dependent response o f embryo development at 48 and 72 hr o f
culture in presence and absence o f CCA mixtures. Dotted curves represent the actual
data points; continuous solid curves represent the best-fit curve. R2 represents the
regression coefficient.
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3.1.2

Embryo Quality

The non embryo-toxic concentration for each CCA component was determined in the
previous section. The nontoxic concentration for each o f the 3 tested compounds was
surprisingly the same at a value o f about 0.5 mg/L. Therefore, in vitro grown mouse
blastocysts cultured in the presence and absence o f 0.5 mg/L o f individual components o f
CCA were taken, stained with Hoechst dye and observed under fluorescent optics (Figure
6A, A ’). Blue color in all images represents the chromatin in the blastomere nuclei that
were stained by membrane-permeable, DNA binding Hoechst stain. Nomarski images
were taken concurrently (Figure 6B, B ’) and were superimposed on the fluorescent
pictures, so that each embryo could be visualized with its nuclear material (Figure 6C,
C ’). When in vitro cultured blastocysts were analyzed for total cell number, most o f
them had a total cell mean number o f 79.4 ± 4 (Table XII). The range o f total cell
distribution for the majority o f them (75%) located between 70-90 cells per embryo. In
cases o f hatching or hatched blastocysts, total cell numbers increased above the normal
range reaching around 9 5 - 100 cell per embryo (Figure 6A). Embryonic total cell
numbers have previously been reported to be a good indicator o f embryo quality and
development rate (Hardy et al., 1989). The higher the cell numbers the better the embryo
quality.
Embryo Quality in the Presence o f Arsenic
Two-cell mouse embryos reaching the blastocyst stage after 72 hr o f culture in the
presence o f 0.5 mg/L arsenic in their culture medium were analyzed to count their total
cell numbers. Although most o f them displayed normal morphology compared with the
control group (Figure 6B ’, B; using Nomarski differential interference contrast optics),
their total cell numbers (52.9 ± 3.8) showed significant reduction (P < 0.0001) compared
with the control group (Table XII; Figure 6A ’, A). This reduction was about 33.4%
compared with control.
In most o f the 0.5 mg/L As-exposed blastocysts, the total cell numbers were located
in the lower ranges (<40 and 40-69) compared with the control group (6.7% at < 40 range
versus 0%; 86.7% at 40-69 range versus 12.5% respectively). Only one embryo had total
cell numbers in the normal range (70-90) (Figure 7).
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Figure 6. Total cell number o f 0.5 As-treated preimplantation embryos. Left panel
represents control group. Right panel represents As-treated group. (A, A ’) Under
fluorescent optics. (B, B ’) Under Nomarski optics. (C, C ’) Superimposed pictures for
(A, B; A ’, B ’).
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Table XII. Total cell number o f mouse blastocysts grown in vitro in arsenic containing
medium
Concentration

Embryo

Total cell number

[mg/L]

Number

(Mean ± SEM)

Control
0.5

16
15

79.4 ± 4.0
52.9 ± 3 .8 “

** Highly significantly different from control, P < 0.0001.

□ Control ■ 0 .5 As

<40

40-69

70-90

>90

Total no. of labeled nuclei

Figure 7. Distribution o f total cell number in mouse blastocysts grown in vitro in the
presence and absence o f arsenic.
Embryo Quality in the Presence o f Chromium
Although the presence o f 0.5 mg/L chromium in the culture medium appeared to be
safe for embryo development (Table V and VI), morphologically normal Cr-treated
blastocyst developed embryos showed highly significant (P < 0.0001) lower total cell
numbers (46.7 ± 2 .1 ) compared with the control group (79.4 ± 4.0) (Table XIII; Figure
9A ’, A). The reduction in total cell numbers was 41.2% compared with control.
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Nearly all (92.8%) Cr-exposed blastocysts had total cell numbers located in the 4069 range, the remaining (7.2%) were located in the < 40 range (Figure 8). All the Crexposed blastocyst embryos exhibited normal external morphology compared with the
control group (Figure 9B’, B) with only a slight reduction in their size when compared
with control.

Table XIII. Total cell number o f mouse blastocysts grown in vitro in chromium
containing medium
Concentration

Embryo

Total cell number

[mg/L]

Number

(Mean ± SEM)

Control
0.5

16
14

79.4 ± 4.0
46.7 ±2.1**

** Highly significantly different from control, P < 0.0001.

□ Control B 0 .5 C r

<40

40-69

70-90

>90

Total no. of labeled nuclei

Figure 8. Distribution o f total cell number in mouse blastocysts grown in vitro in the
presence and absence o f chromium.
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A

A'

Figure 9. Total cell number o f 0.5 Cr-treated preimplantation embryos. Left panel
represents control group. Right panel represents Cr-treated group. (A, A ’) Under
fluorescent optics. (B, B ’) Under Nomarski optics. (C, C ’) Superimposed pictures for
(A, B; A ’, B ’).
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Embryo Quality in the Presence o f Copper
Total cell numbers in 0.5 mg/L Cu-exposed blastocyst embryos were significantly
lower (63.5 ± 3.3) compared with the control group (Table XIV). The reduction in total
cell numbers in the Cu-exposed blastocysts was 20% compared with control. In addition,
around 37.5% o f these blastocysts had total cell numbers located in the normal range
while the remaining 62.5% were in the 40-69 range (Figure 10). Even though, copper
still appeared to have the least problematic effect on embryo development and quality
when compared with the other CCA components.

Table XIV. Total cell number o f mouse blastocysts grown in vitro in copper containing
medium
Concentration

Embryo

Total cell number

[mg/L]

Number

(Mean ± SEM)

Control
0.5

16
16

79.4 ±4.0
63.5 ±3.3**

** Highly significantly different from control, P < 0.005.
□ Control B 0 .5 C u

Total no. of labeled nuclei

Figure 10. Distribution o f total cell number in mouse blastocysts grown in vitro in the
presence and absence o f copper.
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3.2 Oocyte Maturation and Integrity
3.2.1

Cell Cycle Progression o f In Vitro Maturing Mouse Oocytes

When germinal vesicle (GV) oocytes from sexually mature B6CBAF1/J female mice
were isolated from antral follicles and cultured in 5% FCS-Waymouth medium (Figure
11 A), most o f them spontaneously resumed maturation and underwent germinal vesicles
breakdown (GVBD) within 2 hr o f culture (Figure 1 IB). Most o f the control oocytes
possessed a polar body (PB) after 16 hr o f culture and arrested in meiosis II with
condensed metaphase II chromosome (Figure 11C). Only a few oocytes, possibly
derived from preantral follicles, were incompetent to mature and remained in the dictyate
stage with intact GV or arrested in prophase I after GVBD (MI arrested oocytes) or
became degenerated (Figure 11D).

Figure 11. Morphological stages o f oocyte maturation. (A) GV. (B) GVBD. (C) PB.
(D) Fragmented oocyte. Oocytes were observed under Olympus relief contrast optics.
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Cell Cycle Progression o f Oocvtes in the Presence o f Arsenic
Exposure o f mouse oocytes to arsenic during in vitro maturation had a dramatic
effect on maturation kinetics (Table XV). In the presence o f arsenic, maturation rates,
indicated from the number o f metaphase II oocytes, were significantly much lower
compared with the control value (P < 0.0001) and were decreasing with increasing
arsenic concentration in culture medium. Correspondingly, the number o f meiosis I
arrested oocytes after GVBD gradually increased with rising arsenic concentration in
cultured medium and was highly significantly different from control (P < 0.0001 for all
As-treated groups except for 0.1 mg/L As; P < 0.05). At the same time, the number o f
maturation incompetent GV oocytes elevated in all As-treated groups compared with the
control, where a significant difference was found only at 0.1 and 0.7 mg/L As. M ost o f
the As-treated groups showed a significantly higher number o f fragmented oocytes
compared with the control group (Table XV).

Table XV. Cell cycle progression o f mouse oocyte maturation 16 hr post-arsenic
treatment
Concentration
[mg/L]
Control
0.05
0.10
0.70
1.40

Oocytes
number

292
96
138
151
126

Number (%) o f oocytes
GV

MI

Mil

Fragmented

15 (5.1)
6 (6.3)
21 (15.2)**
29 (19.2)**
11 (8.7)

42 (14.4)
30 (31.3)**
31 (22.5)*
56 (37.1)**
62 (49.2)**

231 (79.1)
56 (58.3)**
78 (56.5)**
59(39.1)**
33 (26.2)**

4(1.4)
4(4.1)
8 (5.8)*
7(4.6)*
20 (15.9)“

* Significantly different from control, P < 0.05.
** Highly significantly different from control, P < 0.0001.

There was no single arsenic concentration that showed a safe, nontoxic, effect on
oocyte maturation (Table XV) compared with the control group. All arsenic
concentrations even the lowest tested one, 0.05 mg/L As, showed toxic inhibitory effect
on oocyte maturation. In the presence o f 0.7 mg/L As, the percentage o f As-exposed
oocytes at metaphase II stage was highly reduced and reached half the value o f the
control group (79.1% o f control oocytes reached M il stages versus 39.1% for 0.7 mg/L
As-treated oocytes).

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

64
Moreover, at this concentration the number o f fragmented, GV incompetent and MI
arrested oocytes increased significantly, ~ 2.5-3.5 fold compared with control (Table
XV). Therefore, 0.7 mg/L arsenic concentration appeared to be the TC 50 for oocyte
maturation.
There was a dose-response reduction in the ability o f oocytes to complete the first
meiosis in the presence o f arsenic in the maturation medium (Figure 12). There was
diminution in number o f oocytes with PB after 16 hr o f maturation when 0.05 mg/L As
was applied. The decline became most dramatic with 1.4 mg/L As and exhibited
intermediate values between these concentrations. At the same time, the percentage o f
GV, GVBD and fragmented oocytes gradually increased with rising arsenic
concentrations in the medium reaching a maximum value at 1.4 mg/L arsenic
concentration (Figure 12).

□ control

Q0.05 mg/l As

B0.1 mg/I As

Q0.7 mg/I As

■ 1.4 mg/l As

100-/ I

80

c
0

to
3

60-

to

E

f
CD

o
o
v?

«-

4—

20-

0
GV

GVBD

PB

FRAG

Oocyte stages

Figure 12. Concentration-dependent response o f oocyte maturation 16 hr post-arsenic
treatment. Percentage o f oocytes with GV, GVBD, PB and FRAG is shown.
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Cell cycle progression o f Oocytes in the Presence o f Chromium
The presence o f chromium in oocyte medium showed an inhibitory effect on their
maturation. Number o f oocytes developed to M il significantly decreased with the
presence o f 0.1 mg/L chromium and reached maximum reduction at 2.5 mg/L Cr (P <
0.0001; Table XVI). At the same time, the number o f fragmented oocytes significantly
increased compared with control (P < 0.0001 at 0.5 and 2.5 mg/L Cr; P < 0.05 at 0.1
mg/L Cr). At 2.5 mg/L Cr, 20.9% o f cultured oocytes were fragmented compared with
0% for control. In addition, the rate o f GV oocytes consistently increased approximately
to 4 times the value o f the control (Table XVI).
In the presence o f the 2.5 mg/L Cr in the oocyte maturation medium, all oocytes
failed to emit the first PB and to develop to M il compared with control (0% versus 74.8%
respectively). Some (53.7%) arrested at meiosis I after GVBD, others remained at GV
stage (25.4%) or became fragmented (20.9%). W hen these oocytes were cultured for a
longer time (19 hr), none o f them was able to reach the M il stage, suggesting that this
maturation block was irreversible.

Table XVI. Cell cycle progression o f mouse oocyte maturation 16 hr post-chromium
treatment
Concentration
[mg/L]
Control
0.1
0.5
2.5

Oocytes
number

103
82
91
67

Number (%) of oocytes
GV

MI

Mil

Fragmented

6 (5.8)
5 (6.1)
10(11.0)
17 (25.4)**

20(19.4)
31 (37.8)*
55 (60.4)**
36 (53.7)**

77 (74.8)
43 (52.4)’*
21 (23.1)**
0(0)**

0(0)
3 (3.7)*
5 (5.5)**
14 (20.9)**

* Significantly different from control, P < 0.05.
** Highly significantly different from control, P < 0.0001.

There was a clear concentration-dependant response in the percentage o f oocytes
matured to M il in the presence o f chromium in the culture medium. The number o f Crexposed oocytes reaching M il exhibited an inverse pattern with increasing chromium
concentration, complete inhibition appeared at 2.5 mg/L Cr. Correspondingly, the
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percentage o f GV, GVBD, and fragmented oocytes gradually increased with rising
chromium concentration (Figure 13).
From Table XVI and Figure 13, the TC 50 for chromium on oocyte maturation was
expected to be between 0.1 and 0.5 mg/L. There was no concentration found to have
safe-nontoxic effect on oocyte maturation. Finally, 2.5 mg/L Cr appeared to be severely
toxic with 100% inhibition o f oocyte maturation to MIL
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Figure 13. Concentration-dependent response o f oocyte maturation 16 hr post-chromium
treatment. Percentage o f oocytes with GV, GVBD, PB and FRAG is shown.

Cell Cycle Progression o f Oocytes in the Presence o f Corner
In the presence o f trace amount o f copper in the culture medium (0.05 mg/L Cu),
maturation rate significantly reduced (P < 0.0001) with only 52.4% o f all oocytes was
able to reach MIL This reduction significantly increased with rising copper
concentrations and highly manifested at 5 mg/L Cu (at this concentration, only 1.6% o f
oocytes reached M il, versus 67.3% for control).
Furthermore, the number o f MI arrested and fragmented oocytes significantly
augmented with elevating copper concentration, reaching to the highest value at 5 mg/L

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

67
Cu (Table XVII). In the presence o f this concentration, 83.8% o f in vitro matured
oocytes arrested at meiosis I and 6.5% o f oocytes were fragmented. Succinctly, copper
presence at certain concentrations in oocyte maturation medium induced meiosis I arrest.

Table XVII. Cell cycle progression o f mouse oocyte maturation 16 hr post-copper
treatment
Concentration
mg/L]
Control
0.05
0.10
0.50
2.50
5.00

Oocytes
liumuci

107
105
128
96
90
62

Number (%) of oocytes
GV

MI

8 (7.5)
3 (2.9)
11 (8.6)
7 (7.3)
9 (10.0)
5(8.1)

27
40
61
30
36
52

(25.2)
(38.1)’
(47.6)”
(31.3)
(40.0)*
(83.8)”

Mil

Fragmented

72 (67.3)
55 (52.4)*
50 (39.1)”
55 (57.2)
41 (45.6)*
1 (1.6)“

0 (0)
7(6.7)*
6(4.7)*
4 (4.2)*
4 (4.4)*
4(6.5)*

* Significantly different from control, P < 0.05.
** Highly significantly different from control, P < 0.0001.

From data obtained in (Table XVII), 0.1 mg/L Cu was considered the TC 50 for
oocyte maturation. In the presence o f this concentration only 39.1 % o f cultured oocytes
reached the M il stage with more than 60% (47.7% MI arrested oocytes + 8.6% GV
meiotically incompetent oocytes + 4.7% fragmented oocytes) failed to reach their second
meiosis.
Unexpectedly, in the presence o f 0.5 mg/L Cu, oocyte maturation rate showed a
higher value compared with 0.05 and 0.1 mg/L Cu. Moreover, no significant difference
was found between the percentage o f M il in 0.5 mg/L copper and the control. Further
analysis o f this case is required. By increasing the concentration above 0.5 mg/L Cu,
oocyte maturation returned to the decline pattern and reached a minimum value at 5 mg/L
Cu (Table XVII and Figure 14).
Figure 14 represents the percentage o f GV, GVBD, M il and fragmented oocytes in
the presence and absence o f copper in the cultured medium. Slight significant reduction
in M il was observed at 0.05 mg/L Cu but the reduction became dominant at 5 mg/L Cu
and exhibited intermediate values between these concentrations.
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□ control 0 0 . 0 5 mg/l Cu 0 0 .1 mg/l C u E30.5 mg/l Cu 0 2 . 5 mg/l C u H 5 .0 mg/l Cu

GVBD

PB

Oocyte stages

Figure 14. Concentration-dependent response o f oocyte maturation 16 hr post-copper
treatment. Percentage o f oocytes with GV, GVBD, PB and FRAG is shown.

3.2.2

Spindle Morphology and Chromosome Alignment o f In Vitro Maturing
Oocytes.

Spindle and chromosome behavior in MI and M il in vitro-matured oocytes in the
presence and absence o f individual components o f CCA were analyzed using fluorescent
microscopy. M ost control groups exhibited normal spindle morphology. For control and
treated groups, both MI and M il oocytes were evaluated separately in order to detect if
the abnormality in spindle morphology and chromosome alignment was confined to MI
or M il maturation stage. Metaphase II represents the end point for oocytes development
and maturation before fertilization. Therefore, spindle structure and chromosomal
behavior were compared at this stage between control and treated groups.
To detect if the cause o f meiosis I blocking o f the treated oocytes related to spindle
and chromosome abnormalities, Mi-arrested treated oocytes were analyzed and were
compared at this stage between control and treated groups.
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Spindle M oryholosv and Chromosome Alisnm ent in As-exposed Oocytes
Aberrant spindle shape and unaligned chromosomes were highly presented in all Asexposed oocytes (Table XVIII). At low arsenic concentration, 0.05 mg/L, the extent o f
the disturbance in spindle formation and chromosomal alignment was very high and
highly significant (P < 0.0001) compared with the control group (91.1% versus 20.6% for
spindles; 80.4% versus 8.4% for chromosomes; Table XVIII). Raising the Asconcentration above 0.05 mg/L did not appear to increase the rate o f spindle and
chromosome abnormality but the percentage o f aberrant spindles and misaligned
chromosomes continued to be significantly higher than in the control group (P < 0.0001;
Table XVIII). At the chromosomal level, 1.4 mg/L arsenic-treated oocytes showed the
highest significant rate o f chromosome misalignment compared with the control group
and treated groups (Table XVIII).

Table XVIII. Analysis o f spindle morphology and chromosome alignment in oocytes
16 hr post-arsenic treatment
Concentration Oocyte
[mg/L]
number
Control
0.05
0 .1 0

0.70
1.40

107
56
61
106
52

Chromosome

Spindle
Normal (%)

Aberrant (%)

Aligned (%)

Unaligned (%)

85 (79.4)
5 (8.90)
8(13.1)
21 (19.8)
6(11.5)

22

(2 0 .6 )
51 (91.1)”
53 (86.9)”
85 (80.2)”
46 (88.5)”

98 (91.6)
11 (19.6)
24 (39.3)
30 (28.3)
8(15.4)

9 (8.40)
45 (80.4)” ’a
37 (60.7)” ’a’b
75 (70.7)” ’c
44 (84.6)” ’b’c

** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a and b pairwise comparisons are significantly different, P < 0.05.
c pairwise comparison is highly significantly different, P < 0.0001.

Disturbance in spindle formation and chromosome alignment was characterized in
both MI arrested and M il As-treated oocytes after 16 hr o f culture. However, most o f the
spindle and chromosome abnormalities o f the control group were confined to MI arrested
oocytes (56.3% aberrant spindle at MI versus 5.3% at M il; 18.8% unaligned
chromosomes at MI versus 4% at M il; Table XIX and XX). Although, 0.05 mg/L arsenic
MI arrested oocytes had the highest rate o f spindle abnormalities compared with treated
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groups, there was no statistically significant difference between 0.05 mg/L As and other
treated groups (Table XIX).

Table XIX. Analysis o f spindle morphology and chromosome alignment in MI oocytes
16 hr post-arsenic treatment
Concentration Oocyte
[mg/L]
number

Control
0.05
0.10
0.70
1.40

32
39
22
63
33

Spindle

Chromosome

Normal (%)

Aberrant (%)

Aligned (%)

Unaligned (%)

14 (43.7)
3 (7.70)
3 (13.6)
8 (12.7)
4(12.1)

18 (56.3)
36 (92.3)**
19 (86.4)*
55 (87.3)**
29 (87.9)**

26 (81.2)
7(17.9)
3 (13.6)
13 (20.6)
5(15.2)

6(18.8)
32 (82.1)**
19(86.4)**
50 (79.4)’*
28 (84.8)**

* Significantly different from control, P < 0.05.
** Highly significantly different from control, P < 0.0001.

Metaphase II oocytes, which escaped arsenic-induced meiosis I arrest, had been
separately analyzed for spindle and chromosome behavior. Unexpectedly, there was
significant elevation in the number o f aberrant spindles and chromosomes compared with
the control group (P < 0.0001). Moreover, no statistically significant differences were
found between 0.05 mg/L and 1.4 mg/L As with regard to the abnormalities in spindle
morphology and chromosome alignment. However, 1.4 mg/L As showed the highest
significant rate o f chromosome abnormalities compared with treated groups (Table XX)

Table XX. Analysis o f spindle morphology and chromosome alignment in M il oocytes
16 hr post-arsenic treatment
Concentration Oocyte
Spindle
[mg/L]
number -------------------------------------Normal (%) Aberrant (%)
Control
0.05
0.10
0.70
1.40

75
17
39
35
19

71 (94.7)
2(11.8)
6(15.4)
13 (35.3)
2(10.5)

4 (5.30)
15 (88.2)**'a
33 (84.6)**
22 (64.7)**'a’b
17 (89.5)**’b

Chromosome
-------------------------------------Aligned (%) Unaligned (%)
72 (96.0)
4 (23.5)
20 (51.3)
16 (45.7)
3 (15.8)

3 (4.0)
13 (76.5)**
19 (48.7)**
19 (54.3)**
16 (84.2)**

** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a - d pairwise comparison are significantly different, P < 0.05.
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Generally, in both 0.05 mg/L As MI arrested oocytes and M il oocytes a constant gap
(-10-12% ) in the rate o f aberrant spindle and misaligned chromosome was found. This
gap tends to decrease with increasing arsenic concentration, reaching about 3-5% at 1.4
mg/L As (Table XIX and XX). This indicates that arsenic may have a predominant toxic
effect on spindle morphology rather than on chromosome alignment.
Immunofluorescent images o f spindles and chromosomes, in which spindles were
stained with FITC-conjugated second antibody (shown in green) and chromosomes were
stained with DAPI (shown in blue), showed that metaphase I arrested As-exposed
oocytes had irregular, asymmetrically shaped spindles with misaligned chromosomes
compared with typical anastral, barrel-shaped spindles with condensed chromosomes
aligned at spindle equator o f control group (Figure 15A, A ’). Depending on arsenic
concentration, abnormalities in spindles and chromosomes differed. Most o f the 0.05
mg/L MI arrested As-exposed oocytes possessed aberrant irregular shaped multipole
spindles with individual displaced chromosomes (Figure 15B, B ’; arrows point to two
displaced chromosomes). At 0.1 mg/L As, most oocytes had ball-like spindles, very
short spindles with round poles, and unordered mass-like chromosomes (Figure 15C, C ’).
The interpolar space o f these spindles appeared much shorter compared with control
(Figure 15C). In the presence o f 0.7 mg/L or 1.4 mg/L arsenic, some o f the treated
oocytes possessed asymmetrical spindles with one small pointed fusiform tipping end and
one broad pole (Rhombus-shaped spindle) with misaligned chromosomes (Figure 15D,
D ’; arrows point to three displaced chromosomes). Others showed slightly
hypertrophied, enlarged, rectangular shaped spindles with unordered chromosomal
masses (Figure 15E, E ’). Interestingly, chromosome misalignments in As-exposed
oocytes were found over both intact and disrupted MI spindles, suggesting that MI
spindles can be formed without alignment o f chromosomes. Therefore, chromosome
abnormalities alone cannot determine the integrity o f spindle at MI oocytes. On the other
hand, disrupted spindles generally indicated chromosome misalignments or defects.
On further maturation, most control oocytes emitted a polar body after 9-11 hr and
possessed metaphase II spindles by 12 hr o f maturation. Even after 16 hr culture, most
controls had square anastral spindles with flat poles and well-aligned chromosomes
(Figure 16A, A ’). In contrast to the advanced development o f controls, most As-treated
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oocytes remained blocked in metaphase I with aberrant spindles and misaligned
chromosomes (Table XIX). Moreover, most o f the As-exposed oocytes reaching M il
exhibited abnormal spindles with chromosomes misaligned and disrupted along the
spindle or with completely disrupted spindle. Some o f them, possessed asymmetrical
irregular spindles with fusiform pole and misaligned chromosomes (Figure 16B, B ’;
arrows point to four displaced chromosomes). Others had round poles, small ball-like
spindles with mass-like chromosomes (Figure 16C, C ’ and 16D, D ’). In the cases o f
severely disrupted spindles, chromosomes scattered all over the spindles were seen in 1.4
mg/L arsenic-treated oocytes (Figure 16E, E ’; arrows point to some o f the displaced
chromosomes).

Figure 15. Spindle and chromosome behavior in As-exposed meiosis I oocytes. (A, A ’)
Control. (B, B ’) 0.05 mg/L As. (C, C ’) 0.1 mg/L As. (D, D’) 0.7 mg/L As. (E, E ’) 1.4
mg/L As. A-E Meiotic I spindles stained by anti-tubulin; A ’-E ’ DAPI-stained
chromosomes. Arrows indicate chromosome misalignment.
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Figure 16. Spindle and chromosome behavior in As, Cr and Cu M il exposed oocytes.
(A, A ’) Control. (B, B ’) 0.05 mg/L As. (C, C ’) 0.1 mg/L As. (D, D ’) 0.7 mg/L As. (E,
E ’) 1.4 mg/L As. (F, F ’) 0.1 mg/L Cr. (G, G ’) 0.5 mg/L Cr. (H, H ’) 0.05 mg/L Cu. (I,
I ’) 0.1 mg/L Cu. (J, J ’) 0.5 mg/L Cu. (K, K ’) 2.5 mg/L Cu.
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Spindle Morphology and Chromosome Alignment in Cr-exvosed Oocytes
Exposure o f oocytes to chromium in maturation medium for 16 hr culture appeared
to have a highly significant (P < 0.001) potent toxic effect on spindle morphology and
chromosome alignment compared with the control group. The percentage o f aberrant
spindles and misaligned chromosomes significantly increased in a dose-dependant
manner with elevating chromium concentration in the culture medium (P < 0.0001; Table
XXI). All 0.5 mg/L Cr-exposed oocytes had significantly (P < 0.0001) aberrant spindles
with 80% o f them having misaligned chromosomes compared with the control group. At
2.5 mg/L Cr, all chromium-exposed oocytes significantly exhibited spindle and
chromosome abnormalities compared with the control group (Tables XXI).

Table XXI. Analysis o f spindle morphology and chromosome alignment in oocytes 16
hr post-chromium treatment
Concentration Oocyte
[mg/L]
number
Control
0.1
0.5
2.5

101
62
25
8

Spindle

Chromosome

Normal (%)

Aberrant (%)

Aligned (%)

Unaligned (%)

76 (75.2)
32 (51.6)
0(0)
0(0)

25 (24.8)
30(48.4)" a b
25 (100)" a
8 (100)"’b

87 (86.1)
19 (30.6)
5 (20.0)
0(0)

14(13.9)
43 (69.4)"
20 (80.0)"
8 (100)"

** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a - b pairwise comparisons are highly significantly different, P < 0.005.

M ost o f the spindle and chromosome abnormalities localized and were displayed in
MI arrested oocytes, especially at 0.5 and 2.5 mg/L chromium concentration. At 2.5
mg/L Cr, all MI arrested oocytes exhibited highly significant aberrant spindles with
misaligned chromosomes compared with the control group (P < 0.0001; Table XXII).
This explained why no oocytes in the presence o f 2.5 mg/L Cr concentration were able to
develop to MIL
Even 0.1 mg/L Cr M il oocytes, which escaped Cr-induced meiosis I arrest, displayed
significantly higher rates o f aberrant spindles with unaligned chromosomes compared
with control (50% versus 17.4% for spindle; 69.9% versus 4.3% for chromosome; Table
XXIII).
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Both M I and M il 0.1 mg/L Cr-treated oocytes exhibited higher rates o f chromosomal
abnormalities compared with spindle abnormalities (76.9% versus 50% for MI oocytes;
Table XXII; 69.9% versus 50% for M il oocytes; Table XXIII). Therefore, chromosome
abnormalities alone cannot determine the integrity o f the spindles at MI or M il oocytes,
indicating that chromosomal abnormalities can be found over both intact and disrupted
spindles.

Table XXII. Analysis o f spindle morphology and chromosome alignment in MI
oocytes 16 hr post-chromium treatment
Concentration Oocyte
[mg/L]
number

Control
0.1
0.5
2.5

32
26
25
8

Spindle

Chromosome

Normal (%)

Aberrant (%)

Aligned (%)

Unaligned (%)

19 (59.4)
13 (50.0)
0 (0)
0 (0)

13 (40.6)
13 (50.0) a’b
25 (100)“ a
8 ( 1 0 0 )“ ’b

21 (65.6)
6(23.1)
5 (20.0)
0 (0 )

11 (34.4)
20 (76.9)“
2 0 (80.0)“
8 ( 1 0 0 )“

** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a pairwise comparison is highly significantly different, P< 0.0001.
b pairwise comparison is significantly different, P < 0.05.

Table XXIII. Analysis o f spindle morphology and chromosome alignment in M il
oocytes 16 hr post-chromium treatment
Concentration Oocyte
|mg/i^j
numocr

Spindle
Normal (%)

69
36

57 (82.6)
18(50.0)

Chromosome
Aberrant (%)

12 (17.4)
18(50.0)“
** Highly significantly different from control, P < 0.0001.

Control
0.1

Aligned (%)

Unaligned (%)

(95.7)
13 (36.1)

3 (4.30)
23 (69.9)“

66

Immunofluorescent analysis o f MI and M il Cr-treated oocytes confirmed that
chromium severely interferes with spindle integrity and chromosome alignment (Figure
16 and 17). At 0.1 mg/L Cr, most o f the treated oocytes (MI and M il) possessed irregular
oval shaped spindles (Figure 16F and 17B) with chromosomes located outside the
equator (Figure 16F’ and 17B’; arrows indicate that 3-4 chromosomes were displaced).
In the presence o f 0.5 mg/L Cr, most o f the oocytes had asymmetrical spindles with one
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small and one broad spindle pole (Figure 16G and 17C) with unaligned undefined
irregular chromosomal masses (Figure 16 G ’) or with scattered chromosomes around the
equator (Figure 17C’; arrows point to 4 displaced chromosomes). Moreover, the
centrosomal microtubular organizing center at the spindle poles appeared positioned in a
zig-zag pattern rather than being spatially organized and forming a flat plate as in the
control group (Figure 17C, 17 A).
Interestingly, at 2.5 mg/L Cr, most o f the MI arrested oocytes showed complete
destruction and disappearance o f spindles with the presence o f round undefined
chromosomal masses (Figure 17D, D ’). To exclude the possibility o f being GV oocytes
(without assembled microtubules), images o f GV oocytes were taken and compared with
2.5 mg/L Cr images. Although in both o f them no spindles were recognized, the
appearance o f centralized round small faintly blue nuclear material surrounded by a
nuclear membrane was characterized for GV oocytes (Figure 17E, E ’).

Figure 17. Spindle and chromosome behavior in Cr-exposed meiosis I oocytes. (A, A ’)
Control. (B, B ’) 0.1 mg/L Cr. (C, C ’) 0.5 mg/L Cr. (D, D’) 2.5 mg/L Cr. (E, E ’) GV
oocyte. Green staining = spindle immunofluorescence; blue staining = DAPI-stained
chromosomes. Arrows indicate chromosome misalignment.
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Svindle Morphology and Chromosome Alignment in Cu-exposed Oocytes
Copper presence in trace amount in oocyte maturation medium showed a deforming
toxic effect on spindle and chromosome morphology. The percentage o f abnormal
spindles and unaligned chromosomes significantly appeared (P < 0.0001) at 0.05 mg/L
copper in comparison with control, reaching its maximum value ( 1 0 0 % aberrant spindle
with 92.1% misaligned chromosome) at 5 mg/L copper (Table XXIV). Although there
was slight reduction in the percentage o f aberrant spindles and misaligned chromosomes
between the 0.1 and 0.5 mg/L copper-treated groups, no statistically significant
differences were found between them. A clear significant concentration-dependant
response arose between the percentage o f aberrant spindles and misaligned chromosomes
with an increasing copper concentration in the culture medium.

Table XXIV. Analysis o f spindle morphology and chromosome alignment in oocytes
16 hr post-copper treatment
Concentration Oocyte
Spindle
[mg/L]
number ------------------------------------------Normal (%) Aberrant (%)
Control
0.05
0.10
0.50
2.50
5.00

101
44
54
61
27
38

76 (75.2)
14(31.8)
11 (20.4)
14 (23.0)
4 (14.8)
0 (0)

25 (24.8)
30 (68.2)“ ’a
43 (79.6)“ ’b
47 (77.0)“ ’c
23 (85.2)“ ’d
38(100)” ’a’b’c’d

Chromosome
--------------------------------------Aligned (%) Unaligned (%)
87 (86.1)
22 (50.0)
23 (42.6)
30 (49.2)
8 (29.6)
3 (7.9)

14(13.9)“
22 (50.0)“ ’e
31 (57.4)“ f
31 (50.8)"’8
19 (70.4)“
35 (92.1)” e’

** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a - g pairwise comparison are highly significantly different, P < 0.0001.
c pairwise comparison is significantly different, P < 0.05.

Most o f the MI arrested Cu-exposed oocytes possessed abnormal spindles and
unaligned chromosomes even at low, 0.05 mg/L, copper concentration. Spindle and
chromosome abnormalities progressively increased with elevating copper concentration
in the culture medium (Table XXV). At 0.05 mg/L Cu, the number o f oocytes with
aberrant spindles and misaligned chromosomes increased significantly (P < 0 .0 0 0 1 ), ~
fold compared with control. All 2.5 mg/L and 5 mg/L copper MI arrested oocytes
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exhibited highly significant misaligned chromosomes compared with the control and all
other treated groups (Table XXV).

Table XXV. Analysis o f spindle morphology and chromosome alignment in MI oocyte
16 hr post-copper treatment
Concentration Oocyte
[mg/L]
number

Control
0.05
0.10
0.50
2.50
5.00

32
20
34
34
15
29

Spindle

Chromosome

Normal (%) Aberrant (%)

Aligned (%) Unaligned (%)

19 (59.4)
6 (30.0)
5 (14.7)
8 (23.5)
2(13.3)
0(0)

21 (65.6)
7 (35.0)
14(41.2)
14(41.2)
0(0)
0(0)

13 (40.6)
14 (70.0)*’a,b
29 (85.3)**’c
26 (76.5)**'d
13 (86.7)*’a’e
29 (100)**’b,c’d,e

11 (34.4)
13 (65.0)*’f’8
20 (58.8)*’h l
20 (58.8)**°’k
15 (100)**’f’h,J
27 (100)“ ’8’1,k

* Significantly different from control, P < 0.05.
** Highly significantly different from control, P < 0.0001
Pairs of values compared together indicated by same superscript.
c, d, f and g pairwise comparisons are significantly different, P < 0.05.
a, b, e, h, I, j and k pairwise comparisons are highly significantly different, P < 0.0001.

Interestingly, regardless o f spindle morphology, chromosome misalignment was
observed in 100% o f 2.5 mg/L o f the MI arrested Cu- exposed oocytes compared with
86.7% with aberrant spindle (Table XXV). In the presence o f 5 mg/L copper in the
cultured medium, all MI oocytes exhibited abnormal spindles with misaligned
chromosomes compared with the control and other treated groups (P < 0.0001). This
explained why only 1.6 % o f 5 mg/L copper exposed oocytes were able to develop to M il
(Table XVII).
Metaphase II Cu-exposed oocytes exhibited abnormalities in spindle morphology
and chromosome behavior. Abnormalities progressively increased in a dose-dependant
manner to copper’s presence in the culture medium. Disturbance in spindle formation
showed a higher tendency with increasing copper concentration compared with
chromosome misalignment. All M il Cu-exposed oocytes had a higher percentage o f
aberrant spindles in compared with misaligned chromosomes. Apparently at 5 mg/L Cu,
all M il Cu-exposed oocytes possessed aberrant spindles with only 66.7% o f them having
misaligned chromosomes (Table XXVI).
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Table XXVI. Analysis o f spindle morphology and chromosome alignment in M il
oocyte 16 hr post-copper treatment
Concentration Oocyte
[mg/L]
number

Control
0.05
0.10
0.50
2.50
5.00

69
24
20
27
12
9

Spindle

Chromosome

Normal (%) Aberrant (%)

Aligned (%)

57 (82.6)
8 (33.3)
6 (30.0)
6 (22.2)
2 (16.7)
0 (0)

12 (17.4)
16 (66.7)**a
14 (70.0)**
21 (77.8)*’
10 (83.3)*
9 (100)**’a

66 (95.7)
15 (62.5)
9 (45.0)
16 (59.3)
8 (66.7)
3 (33.3)

Unaligned (%)
3 (4.3)
9 (37.5)**
11 (55.0)**
11 (40.7)**
4 (33.3)’*
6 (66.7)**

* Significantly different from control, P < 0.05.
** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a pairwise comparison is significantly different, P < 0.05.
All M il copper-treated oocytes showed significantly higher percentage o f misaligned
chromosomes compared with control (P < 0.0001). Although the percentage o f
misaligned chromosomes at 0.5 mg/L and 2.5 mg/L showed a slight drop compared with
0.1 mg/L, no significant differences were found between them (P = 0.333 for 0.5 mg/L
Cu; P = 0.234 for 2.5 mg/L Cu; Table XXVI).
The severity o f the abnormality in spindle morphology and chromosome behavior in
both MI arrested Cu-exposed oocytes and M il treated oocytes, was related to copper
concentration. Most o f the Mi-arrested copper-treated oocytes exhibited abnormal
spindle morphology with misaligned chromosomes compared with typical anastral,
barrel-shaped spindles with aligned chromosomes at the equator o f the control (Figure
18A, A ’). At 0.05 mg/L copper, some oocytes showed slim, elongated spindles with or
without aligned chromosomes. Others showed round oval-shaped spindles with
chromosomes spread all over the spindle (Figure 18B, B ’). W ith increasing copper
concentration in the culture medium to 0.1 mg/L copper, some o f the oocytes still had the
oval-shape spindles but the remaining had completely disrupted irregular-shaped spindles
with chromosomes scattered all over the spindles (Figure 18C, C ’). Some o f the 0.5
mg/L, most o f the 2.5 mg/L and all o f the 5 mg/L MI arrested Cu-exposed oocytes had no
microtubule or spindle structure (Figure 18D; E; F) with chromosomes spread throughout
the cytoplasm (Figure 18D’; E ’; F ’; arrows point to some o f the scattered chromosomes).
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Most o f the Cu-exposed oocytes reached to M il exhibited aberrant spindles with
misaligned chromosomes. Some o f them possessed slim shaped elongated spindles. In
some o f these, condensed chromosomes still aligned at the spindle equator (Figure 16H,
H ’). In others, individual chromosomes were displaced or sometimes they were even
positioned outside the central array o f microtubules between opposite spindle poles
(Figure 161,1’; arrow points to two displaced chromosomes). Increasing copper
concentration in the culture medium was associated with complete disruption o f spindles
with chromosomes spread throughout the disrupted spindles (Figure 16J, J ’ and K, K ’;
arrows point to some o f scattered chromosomes).

Figure 18. Spindle and chromosome behavior in Cu-exposed meiosis I oocytes. (A, A ’)
Control. (B, B ’) 0.05 mg/L Cu. (C, C ’) 0.1 mg/L Cu. (D, D ’) 0.5 mg/L Cu. ( E ,E ’)2 .5
mg/L Cu. (F, F ’) 5 mg/L Cu. Oocytes observed under a fluorescent microscope. A -F
Anti-tubulin stained meiotic I spindles; A ’-F ’ DAPI-stained chromosomes. Arrows
indicate displaced chromosomes.
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3.3 Evaluation of Sperm Function and Viability
3.3.1

Evaluation of Sperm Function in the Presence of Individual CCA
Components

When sperm isolated form the vas deference o f sexually mature CD1 male mice
were diluted and incubated in Earle’s balanced salt solution (EBSS), they exerted
vigorous forward progressive movement (fpm). After about 30 min, they slowed down
and began to associate head to head clusters with sluggish circular movements. By 4 hr
incubation, most o f the clusters had broken up and most o f the control untreated sperm
exhibited category 4 motility with rapid purposeful fpm without hyperactivation. At this
time, sperm motility index (SMI) o f the control group reached its peak. A significant
reduction in the SMI at 4 hr indicated the presence o f toxic contaminants in the medium.
To determine if the SMI reduction was due to percentage o f motile sperm reduction
or forward progressive quality (FPQ) score reduction, these two components o f the SMI
were analyzed for each treated group and compared with the control and the other treated
groups.
Sperm Function in the Presence o f Arsenic
With arsenic presence in the sperm medium, SMI exhibited a significant reduction (P
< 0.0001) compared with the control group. At the same time, sperm motility percentage
showed a significantly lower value in the As-treated groups compared with the control
group. However, the FPQ score was significantly higher with a 4.5 score in the Astreated groups compared with 4 for the control group. A score o f 4.5 indicted that 50%
o f sperm showed grade 4 motility and the remaining were in the hyperactivated stage.
Sperm motility and SMI exhibited a significant reduction in the presence o f 0.5
mg/L As, this drop became more obvious and significant (P < 0.0001) with increasing
arsenic concentration in incubation medium, reaching the maximum value at 1.5 mg/L As
concentration (Table XXVII). Therefore, a concentration-dependant response for SMI
and sperm motility percentage was demonstrated with arsenic present in the sperm
medium. On the other hand, the FPQ showed a constant significantly higher score in all
As-exposed sperm compared with the control group.
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Table XXVII. Analysis of sperm function 4 hr post-arsenic treatment
Concentration
[mg/L]

Number Mobility percentage mean ±
SEM

FPQ mean ±
SEM

SMI mean ±
SEM

Control
0.5
1.0
1.5

12
12
12
12

4.0 ± 0
4.5 ± 0**
4.5 ± 0**
4.5 ± 0**

920.0 ±
845.5 ±
573.8 ±
379.7 ±

57.8 ±1.1
41.8 ± 1.8*’ a
35.0 ± 4.0**'b
18.8 ± 0.5**’a,b

16.3
35.4c’d
3.9**'c' e
9.7**'d’e

** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a - e pairwise comparisons are significantly different, P < 0.0001.

Arsenic TC 50 for sperm function seemed to be located between 1-1.5 mg/L. In the
presence o f 1-1.5 mg/L arsenic, the percentage o f motile sperm was highly reduced and
sperm exhibited half the value o f the control group (57.8 ± 1.1% o f the control were
motile compared with 35.0 ± 4.0 -18.8 ± 0.5% for 1-1.5 mg/L As concentration). In
addition, the SMI value at 1-1.5 mg/L showed half the value o f the control (920.0 ± 16.3
for control compared with 573.8 ± 3.9 for 1 mg/L As; 379.7 ± 9.7 for 1.5 mg/L As;
Table XXVII).

Sperm Function in the Presence o f Chromium
After 4 hr incubation o f sperm in chromium containing medium, there was a dosedependant reduction in SMI. All the Cr-treated groups showed significantly lower SMI
compared with the control group. These lower SMI values resulted from the reduction in
motility percentage and FPQ score (Table XXVIII). No significant differences were
found between the control group and the other treated groups or between the treated
groups with each other concerning FPQ score.
At 1.5 mg/L chromium concentration, only 23.0 ± 1.2% o f sperm were motile
compared with 57.8 ± 1.1% for control. Moreover, at 1.5 mg/L chromium concentration
there was more than 50% reduction in SMI value compared with the control group (368.0
± 19.6 versus 920.0 ± 16.3 respectively; Table XXVIII). Therefore, 1.5 mg/L Cr was
considered as the

T C 50

for sperm.
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Table XXVIII. Analysis of sperm function 4 hr post-chromium treatment
Concentration
[mg/L]

Number Mobility percentage mean ±
SEM

FPQ mean ±
SEM

SMI mean ±
SEM

Control
0.5
1.0
1.5

12
12
12
12

4.0 ± 0
3.5 ±0.6
3.5 ±0.6
4.0 ± 0

920.0 ± 16.3
523.5 ± 58.4**
426.3 ± 47.5**
368.0 ± 19.6**

57.8 ± 1.1
43.0 ± 2.3*’a
35.8 ± 3.8**,b
23.0 ± 1.2**,a,b

* Significantly different from control, P < 0.05.
** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a pairwise comparison is highly significantly different, P < 0.0001.
b pairwise comparison is significantly different, P < 0.05.

Sperm Function in the Presence o f Copper
Exposure o f sperm to copper containing medium appeared to have a dramatic toxic
effect on sperm function. The percentage o f motile and FPQ score o f the Cu-treated
groups showed significantly lower values compared with the control group (Table
XXIX).
Correspondingly, the SMI o f Cu-treated groups was significantly reduced.
Percentage o f motile sperm, FPQ and SMI exhibited a concentration-dependant response
to the presence o f copper in the medium. A highly significant drop in all o f the
previously mentioned values was observed when copper concentration increased from 0.5
to 1.5 mg/L in the sperm medium, reaching the maximum reduction at 2.5 mg/L Cu,
where only 0.6 ± 0.5% o f the treated sperm were motile and expressing twitching without
any forward progressive movement.
At 0.5 mg/L copper, SMI was about half o f the control value (500.0 ± 43.4 versus
920.0 ± 16.3; Table XXIX). In addition, the FPQ score and sperm motility percentage
exhibited significant reduction in their mean values compared with the control group.
Therefore, 0.5 mg/L Cu was considered as the TC 50 for sperm function.
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Table XXIX. Analysis o f sperm function 4 hr post-copper treatment
Concentration
[mg/L]

Number Mobility percentage mean ±
SEM

FPQ mean ±
SEM

SMI mean ±
SEM

Control
0.5
1.5
2.5

12
12
12
12

4.0 ± 0
3.3 ± 0.6cd
1.9 ±0.1**’°
0.9 ± 0.5**’d

920.0 ± 16.3
500.0 ±43.4**’ef
10.8 ± 1.0**’e
1.3 ± l.l**’f

57.8± 1.1
47.3 ± 1.5**’a,b
3.8 ± 0.5**’a
0.6 ± 0.5**’b

** Highly significantly different from control, P < 0.0001.
Pairs of values compared together indicated by same superscript,
a - f pairwise comparisons are highly significantly different, P < 0.0001.
c pairwise comparison is significantly different, P < 0.05.

3.3.2

Evaluation of Sperm Viability

When mouse sperm were incubated for 5 min with propidium iodide, percentage o f
the cells (dead cells) incorporated the stain and were identified by fluorescent microscopy
(Figure 19). Immotile dead sperm showed a bright red orange fluorescent head while the
immotile viable one did not stain. The average sums o f the percentage o f immotile
unstained viable sperm o f control and treated groups were determined. The lower the
value the more toxic the tested compound on sperm viability.
From the previous experiment’s results, 0.5 mg/L appeared to be the lowest toxicsubtoxic concentration for all tested compounds on sperm function. In the presence o f
this concentration, sperm motility percentage, FPQ and SMI showed a slight reduction
compared with the control group. Therefore, sperm viability was used as a second
indicator to detect sperm toxicity at 0.5 mg/L concentration.
Sperm Viability in the Presence o f Arsenic
Even though the presence o f 0.5 mg/L arsenic in sperm medium trended to a lower
but insignificant effect on SMI (Table XXVII) compared with control, viability o f 0.5
mg/L As-treated sperm was greatly reduced. W hen sperm incubated with 0.5 mg/L As
for 4 hr were stained with propidium iodide, the number o f immotile unstained viable
cells was significantly lower when compared with the control group (P < 0.0001) (6.4 ±
3.9% versus 22.5 ± 0.4% respectively; Table XXX). Correspondingly, the number o f
stained immotile non-viable cells was greater than the number o f control stained cells
(Figure 19A’, A). This indicates that 0.5 mg/L arsenic has a spermicidal effect.
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Using Nomarski differential interference contrast optics, images o f control and
treated sperm were taken (Figure 19B, B ’), and superimposed on the corresponding
fluorescent images (Figure 19C, C ’). Control superimposed images showed 3 out o f 5
sperm were fluorescent in that field (Figure 19C) while sperm in the 0.5 As-treated
groups were all fluorescent in that field (Figure 19C’).

Table XXX. Sperm viability in the presence o f arsenic
Concentration

Number

Mean ± SEM

12

22.5 ± 0.4
6.4 ± 3.9**

[mg/L]
Control
0.5

12

** Highly significantly different from control, P < 0.0001.

Sperm Viability in the Presence o f Chromium
Sperm viability was greatly affected by the presence o f chromium in the medium. At 0.5 mg/L
chromium, only 7.1 ± 2.0% o f immotile sperm were viable compared with 22.5 ± 0.4% for the
control (Table XXXI). Thus most (92.9%) o f the immotile chromium-treated sperm were nonviable.

Table XXXI. Sperm viability in the presence o f chromium
Concentration

Number

Mean ± SEM

12

22.5 ± 0.4
7.1 ±2.0**

[mg/L]
Control
0.5

12

** Highly significantly different from control, P < 0.0001.
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Figure 19. Viability o f mouse sperm in the presence o f arsenic. Left panel (A, B, C)
represents control. Right Panel (A% B ’, C ’) represents 0.5 As-treated sperm. (A, A ’)
Under fluorescent microscope. (B, B ’) Under Nomarski optics. (C, C ’) Superimposed
images.
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Sperm Viability in the Presence o f C om er
Sperm viability was significantly reduced when 0.5 mg/L copper was added to the sperm
medium. Only 4.9 ± 2.2% o f the immotile sperm were viable compared with 22.5 ±
0.4% for the control (Table XXXII). Therefore, 0.5 mg/L copper is a potent toxin for
sperm viability.

Table XXXII. Sperm viability in the presence o f copper
Concentration

Number

Mean ± SEM

12

22.5 ± 0.4
4.9 ± 2.2**

[mg/L]
Control
0.5

12

**Highly significantly different from control, P < 0.0001.
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CHAPTER IV
DISCUSSION
A considerable degree o f controversy has surrounded the safety o f CCA-treated
wood. This controversy has centered primarily on the toxicity o f arsenic and chromium
and the potential for these metals to be released from the wood. Several studies have
reported the possibility o f these toxic metals to leach from the wood and be bioavailable
under certain circumstances.
CCA toxicity on the reproductive system may be demonstrated as abnormality in the
gametes in the form o f decrease in number or increase in abnormal morphology and/or
abnormality in embryonic and fetal development. CCA compounds are found in many
places around us. The resulting long-term exposure may cause chronic toxicity within
sensitive reproductive developing organs. Both male and female gametes are very
sensitive cells. Chronic toxicity could cause such severe changes that the damage to the
germ cells could result in permanent decrease in number or increase in abnormal
morphology. In addition, maternal exposure during the prenatal or natal period to the
CCA compound and its individual components may have an irreversible toxic effect on
embryo development and quality. The manifestation o f CCA toxicity and its individual
components may be noted as alternations in fertility (gamete effect) or pregnancy
outcome (embryo effect).
To illustrate the validity o f our hypothesis, explanations for the obtained results o f
each topic, their significance (in this particular study or other studies) and the potential
postulated mechanisms will be the theme for this chapter.

4.1

Impacts on Embryo Development and Quality
The hypothesis to be tested was whether CCA components and their mixtures have

deleterious effects on embryo development (growth and differentiation).
4.1.1

The Obtained Results

In vitro culture o f two-cell mouse embryos has been used routinely as a quality
control standard for media and supplements for human IVF. One o f the driving forces for
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its usage until now is its sensitivity to detect toxins in the culture medium. The data
presented in this thesis demonstrate a sensitive model for exploring metal embryotoxicity
in early mammalian embryos and provide a system for direct comparison o f the toxicities
o f various metals.
Arsenic
Arsenic often gets the most attention in any discussion o f the hazards o f CCA and
pressure treated wood. Several studies have reported that prenatal arsenic-exposed
laboratory animals produced birth defects and malformations in their offspring
(Aschengrau et al., 1989; Shalat et al., 1996; Shephard, 1998). However, these results
depend on route o f administration (intravenous, intraperitonial or oral), timing o f
administration and the general conditions o f the animal. All these factors were
eliminated in this study with the usage o f a whole embryo culture system.
In the present study, murine embryonic development in the presence o f 0.5 mg/L or
less arsenic concentration in the culture medium did not produce any significant
difference compared with the control group. After 72 hr o f culture, all 0.5 mg/L Astreated two-cell embryos reached the morula-blastocyst stage (Table III). Increasing
arsenic concentration above 0.5 mg/L was accompanied by a dose-dependant decrease in
embryonic development in the form o f a drop in the number o f morula-blastocyst
embryos and elevation in fragmented-degenerated embryos. Arsenic concentration o f 1.5
mg/L or more caused severe toxic lethal effect on embryo development with 100%
lethality (Table III and Table A. 2). Between the previous nontoxic (0.5 mg/L or less)
and highly toxic (1.5 mg/L or more) concentrations,

T C 50

appeared to be around 1.1 mg/L

As.
Total cell numbers, an index o f cell proliferation, have been used as a second
parameter o f embryo development and a good indicator o f embryo quality. The embryo’s
total cell number was found to be a more sensitive parameter than blastocyst formation
for determining a toxicity threshold concentration. Even though embryonic development
after 72 hr o f culture in the presence o f 0.5 mg/L did not show any significant difference
compared with control regarding the blastocyst formation rate or blastocyst morphology,
morphologically normal blastocyst cultured in the presence o f 0.5 mg/L As exhibited
highly significantly lower total cell numbers compared with the control group (Table XII;
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Figure 6 ). Lower total cell numbers characteristic o f delayed blastocyst development
may be attributed to a slower proliferation in both trophectoderm cells (TE) and inner cell
mass (ICM). Blastocysts with lower TE suggested that events associated with placental
development and implantation m aybe greatly affected (Van Soom et al., 2001). Minimal
numbers o f ICM are required to obtain a pregnancy, blastocysts with lower ICMs are less
viable, at the same time they are responsible for biochemical pregnancies where there is
an initial increase in the levels o f hCG but no fetal development. W hether these
blastocysts with low cell numbers resulted from TE or ICM reduction is a topic that
requires further investigation.
Finally, two main parameters should be considered. The first one relates to how the
obtained results can be applied to determine arsenic toxicity on human preimplantation
embryos. The National Academy o f Science noted that humans may be even more
sensitive to the adverse arsenic reproductive effect than the standard laboratory animals
because rodents are more efficient methylators than humans and completely detoxify
inorganic arsenicals (Hughes et al., 1994). Moreover, it was shown that humans are
found to be more sensitive to arsenic than most laboratory animals by a factor o f as much
as 300 (ATDSR, 2000a). The second parameter relates to the form o f arsenic in the CCA
compound. Although the form o f arsenic in CCA is pentavalent, the same form has been
used in this study, more in vivo embryotoxicity is expected with the tested arsenic
concentration because this pentavalent form will be reduced in vivo to the more toxic
trivalent form, prior to metabolism by methylation (Machado et al., 1999). From all o f
the above, we conclude that embryonic exposure to any trace dose o f arsenic may have a
predominant embryotoxic effect that m ay be presented by embryo-fetal lethality, fetal
anomalies or birth defects.
Chromium
Although the form o f chromium in CCA is hexavalent (classified as type A human
carcinogen; ATSDR, 2000b), less attention is paid to the chromium in CCA because the
treatment process converts it to the more benign trivalent chromium. However, if during
the pressure treating process the hexavalent chromium is not fixed completely and
converted to the more benign trivalent form, it can leach out o f the wood in its original
form even if virtually all o f the chromium is fixed.
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Several studies have demonstrated that chromium embryotoxicity and teratogenicity
depend on the time, the dose and the route o f administration (Gale, 1978; Iijima et al.,
1979; Trivedi et al., 1989). Common features o f chromium toxicity were embryotoxicity
(embryocidal), fetotoxicity (reduced fetal weight and increase fetal anomalies), higher
incidence o f resorption and postimplantation loss. The mode o f action was not explained
in any o f these previous studies. Only one study, using in vitro mammalian cell culture
showed that chromium exposure increases oxidative stress and DNA breaks, with no
decrease in cell viability, when the chromium concentration exceeded 20 mg/L (De Flora
and Wetterhahn, 1989).
The results presented in this thesis were able to mix and reshape the previous
information to obtain a final clear conclusion regarding chromium toxicity. In a nutshell,
0.5 mg/L o f hexavalent chromium appeared to have no effect on cell viability because
embryonic development in its presence did not show any significant difference from
control in embryo cultured media. However, their total cell numbers were much lower
compared to control. Reduction in the total embryonic cell numbers especially in TE
cells may explain the higher incidence o f resorption and postimplantation loss with
chromium exposure. Moreover, fetotoxicity in the form o f reduced fetal weight and
increase fetal anomalies can be explained if the reduction in the total cell numbers was
localized to the ICM. One other outcome o f the performed experiment is that, chromium
embryocidal effect appeared if its concentration exceeded 1.9 mg/L and reached
maximum at 3 mg/L Cr. The difference in the toxic chromium concentration in this study
(1.1 mg/L) from the previous reported information (20 mg/L) indicates the sensitivity o f
the mouse embryo culturing system in detecting a toxin in the culture medium compared
with other mammalian cell cultures.
C o w er
Embryonic development and blastocyst formation rate did not exhibit any changes
with exposure to 5 mg/L or less copper (Table A.6). However, both o f them showed
marked reduction if copper concentration exceeded 7 mg/L. Copper toxicity may be
through inhibition o f embryonic division at 7 mg/L Cu, then by increasing embryo
lethality (embryocidal effect) at 8 mg/L or more. Surprisingly, at 0.5 mg/L Cu, exposed
blastocyst had poor quality with low total cell numbers. Even though, 0.5 mg/L copper
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did not show any harmful effects on embryonic development, blastocyst quality was
poor.
CCA Compound
The combination o f known toxins and carcinogens into a single chemical formula
may result in an even stronger toxin, carcinogen and teratogen. CCA may present a
greater acute toxicity hazard than exposure to its constituent compounds separately,
particularly if the dose o f at least one o f the compounds is at a level which would be toxic
if administrated alone (Mason and Edwards, 1989). Although, our study confirmed the
previous conclusion, we proved here that even mixing them in their subtoxic doses or
even in nontoxic doses (the dose o f each one at the level that would not be toxic i f —2-3
fold o f the compound was administered alone) appeared to having very high
embryotoxicity. The only CCA mixture that did not show toxic effects on embryo
development and blastocyst formation rate was one-tenth the nontoxic-subtoxic
concentration o f each compound. However, most o f these blastocysts were
morphologically abnormal and were characterized by one or more o f the following
features: unincorporated blastomeres, multiple cavities (possibly intracellular vacuoles),
no discrete ICM visible or low numbers o f mural TE cells.
From the above discussion, we conclude that embryonic exposure to arsenic,
chromium and copper concentrations o f even 0.5 mg/L, appeared to have a bad toxic
effect on embryo quality with no obvious reduction in embryonic developmental stages.
Combining these individually-tested compounds, in a CCA mixture, produced a
synergistic embryotoxic effect.
4.1.2

Expected Mechanisms.

Numerous mechanisms may help to explain the toxicity o f each metal tested in this
study on embryo development. For examples, oxidative damage to cells may be
associated with each o f the compounds tested here, with the damage occurring through
either direct oxidative interactions (arsenic, chromium) or activation o f reactive oxygen
species through secondary mechanisms (copper). Additionally, metalic interactions with
DNA, either through direct metal complexion (as in arsenic which bind to sulphhydryl
groups o f histones and nucleic acid) or metal-catalyzed oxidative damage (as in
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chromium and copper), may be another route for embryotoxicity. Moreover, arsenic
impairs assembly and disassembly o f microtubules, presumably by binding to protein
sulphhydryl groups, and thus may interfere with the mitotic spindle formation and
embryonal cell division (Leonard and Lauwerys, 1980). Such actions could interfere
with embryonic cell proliferation and/or differentiation.

4.2 Impacts on Oocyte Maturation and Spindle-Chromosome Behavior
The hypothesis to be tested was whether CCA components have toxicological effects
on oocyte maturation and integrity.
4.2.1

The Obtained Results

In mitosis, checkpoints exist which sense the integrity o f the mitotic spindle at
metaphase (Hartwell and Weinert, 1989). There appear to be similar checkpoints at the
first meiotic metaphase o f mouse oogenesis, one that monitors spindle integrity and one
activated by drugs interfering with actin polymerization (Wassarman et al., 1976).
Several studies concluded that the potential o f a drug to induce abnormalities in
mammalian oocytes is related to its mode o f activity by either inducing damage, which
triggers meiotic arrest, or affecting checkpoint controls. Cytochalasin D and chloral
hydrate appear to belong to the former class (Eichenlaub-Ritter and Betzendahl, 1995).
In contrast, cycloheximide and diazepam (Soewarto et al., 1995) as well as maternal age
(Liu and Keefe, 2002) seem to have the opposite activity in promoting or delaying
meiosis while checkpoints become leaky.
The present study shows unambiguously that a trace amount o f arsenic, chromium or
copper inhibits maturation o f mouse oocytes. The metal compounds block some oocytes
in GV stage but predominantly delay the cell-cycle progression and arrest oocytes
irreversibly in meiosis. This meiotic arrest became more potent with the increase o f
metal compound concentration in culture medium reaching TC 50 at 0.7 mg/L arsenic, 0.10.5 mg/L chromium and 0.1 mg/L copper (Table XV; XVI; XVII). Oocyte maturation
appeared to be inhibited in the presence o f low concentrations o f arsenic, chromium or
copper. The higher the metal concentration, the greater the number o f arrested MI
oocytes. At low tested concentrations, a higher percentage o f oocytes were able to
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mature to M il compared with the higher concentrations. However, spindle aberration and
chromosome misalignment o f these M il oocytes did not show any significant difference
compared with the other M il treated oocytes. Indicating that low concentrations o f the
tested compounds may affect the metaphase/anaphase checkpoint, allowing oocytes with
aberrant spindles and misaligned chromosomes to progress to MIL Studies o f oocytes
from XO females indicate that chromosome misalignment at metaphase does not induce a
delay in anaphase onset (Le Marie-Adkins et al., 1997). Despite an apparent delay in the
congression o f the X chromosome during prometaphase and a significant proportion o f
metaphase cells with a misaligned X chromosome, no evidence o f accumulation o f cells
at metaphase I among oocytes from XO females was found.
Given the role o f the metaphase/anaphase checkpoint in ensuring proper
chromosome segregation, the lack o f this important control mechanism during female
meiosis is surprising. In fact, the most plausible explanation (for our results and the other
study result) was that the cell cycle control machinery does indeed exist, but is
operationally impaired because o f the excessive volume o f the mammalian oocyte
(LeMarie-Adkins et al., 1997). Moreover, it becomes more leaky with maternal age or
chemical exposure (Liu and Keefe, 2002; Soewarto et al., 1995).
The obtained results in this thesis, suggested that there is a meiosis checkpoint
control. This checkpoint became more permissive with chemical exposure (especially at
lower concentration) and thereby allowed the meiotically incompetent oocytes to resume
maturation and to progress from MI to M il regardless chromosome misalignment. Most
control M il oocytes had normal bipolar spindles with well aligned chromosomes in
equator. Apparently, most o f the abnormality in spindles and chromosomes o f control
groups localized to MI arrested oocytes. Aberrant spindles were found in 56.3, 40.6 and
40.6% o f MI oocytes compared with 5.3, 14.7 and 14.7% in M il oocytes. In addition,
unaligned chromosomes were represented in 18.8, 34.4 and 34.4% o f MI oocytes
compared with 4, 4.3 and 4.3%. However, this was not the case o f metaphase II oocytes
which escaped the As, Cr or Cu -induced meiosis I arrest. Most o f these M il oocytes
have aberrant spindles with displaced chromosomes. This was only seen at lower
concentration o f the tested compounds. However, at higher dose all/most o f the oocytes
failed to progress to MIL
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4.2.2

Expected Mechanisms

Numerous mechanisms may help to explain the disturbance in spindle organization
o f each metal tested in this study. Direct effect on the integrity, function and positioning
o f centrosomes deduced from the asymmetric alignment o f microtubule organizing
centers (MTOCs) in the first meiosis and the fusiform shapes o f the poles o f the treated
oocytes is one mechanism. Oocytes possess multiple MTOCs rather than pairs o f
centrioles at their spindle poles. These MTOCs are essential for the formation o f the
spindle and proved to be very sensitive for the presence o f many drugs. MTOCs acquire
components such as 7 - tubulin, centrin, cell-cycle regulating enzymes and other proteins
(Eichenlaub-Ritter and Betzendahl, 1995) at or before the transition to metaphase.
Tested compounds- AS2 O 5 , Cr 0 3 , and CuO, may interfere with these processes and
therefore lead to spindle abnormalities which trigger meiosis I arrest. Furthermore, metal
interactions with mitochondria either through direct metal complexion (as in arsenic
which substitutes phosphorous in mitochondria) or metal-catalyzed oxidative stress (as in
arsenic, chromium and copper) may be another mechanism for spindle aberrations.
Oxidative stress damages proteins that may involve microtubules and small molecules
important for spindle organization. Lastly, arsenic, chromium and copper compounds
may have a triggering action on the metaphase I checkpoint judging from the potent and
irreversible arrest at MI.
Chromosome displacements were a common feature in all M i-arrested treated
oocytes even at lower concentration (Table XIX; XXII; XXV). M any factors may be
linked to this event. Mitochondrial dysfunction and deficiencies in energy production
(arsenic uncouples oxidative phosphorylation and diminishes ATP production; Shalat et
al., 1995) could indirectly influence microtubule turnover and the activity o f motor
proteins. This could disrupt microtubule motor proteins involved in assembling o f the
chromosomes at the metaphase plate, tethering the kinetochore to spindle microtubules
(Wood et al., 1997) and triggering the spindle checkpoint in the response to the status o f
chromosome alignment (Chan et al., 1998). This explains the frequent disturbed
alignment o f chromosomes at the equator. On the other hand, oxidative stress has been
publicized to induce disturbances in chromosomal distribution in mouse oocytes (Liu and
Keefe, 2002). Arsenic, chromium and copper compounds toxicity have been related to an
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increase in the oxidative stress in the exposed cells (Huang and Lee, 1996; De Flora and
Wetterhahn, 1989; Bremner, 1998). Oxidative stress may directly involve DNA and
chromosomal damage and/or indirectly damage the chromosome or kinetochore
associated proteins ending with chromosomal displacement.
The fidelity o f cell division is ensured by checkpoint mechanisms assuring that
strategic events occurring during one phase o f the cell cycle are completed before the
next phase o f the cycle is initiated. One such mechanism operates at metaphase/anaphase
transition to delay the onset o f anaphase in the cells with defective spindle formation or
chromosome misalignment. The imposed delay provides an opportunity for the
correction o f defects that would predispose to errors in chromosome segregation at
anaphase. Meiotic segregation errors have disastrous consequences, since they result in
the production o f abnormal gametes. Thus, the metaphase/anaphase checkpoint would be
expected to be o f particular importance during meiotic cell division.

4.3 Impacts on Sperm Function and Viability
The hypothesis to be tested was whether CCA components have deleterious effects
on sperm function.
4.3.1

The Obtained Results

All the tested compounds had an inhibitory effect on sperm motility and SMI. In our
experiments, all the treated sperm, except those arsenic-treated, exhibited a great
reduction in forward progressive movement compared with the control group. This result
was expected as the reduction in motility percentage is usually accompanied with
reduction in FPQ. However, this was not the scenario in arsenic-treated sperm.
Although, there was a reduction in sperm motility percentage, 50% o f sperm exhibited
grade 4 FPQ and the remaining showed hyperactivation after 3-4 hr incubation and even
persist at

6

hr. The tested compound not only affected sperm motility but also affected

sperm viability. Almost all immotile sperm were non-viable even at the lower tested
concentration (0.5 mg/L) indicating that, arsenic, chromium and copper are very potent
spermicidal.
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Copper is considered the least problematic metal in the CCA compound (Fields,
2001). In this study, copper appeared to have the least toxic effect on embryos.
However, this was not the case for sperm function. Copper exhibited the most
detrimental effect on sperm function and viability compared with arsenic and chromium.
Copper intrauterine devices (IUD) prove to be a highly effective method o f contraception
through affecting sperm motility and survival compared with non-medicated IUD. The
amount o f the copper released from IUD in vivo was around 11.4 ± 4.7 /zg/mL (11.4 ±
4.7 mg/L) and varied according to the age o f the device and the uterine stage (Arancibia
et al., 2003). Results showed that copper, at 100 /zg/mL (100 mg/L) concentrations,
caused significant decreased in sperm motility, viability and acrosomal reaction in vitro
(Roblero et al., 1996). Our study found that the presence o f even 0.5 mg/L o f copper in
sperm medium greatly affected sperm motility and viability. The difference in our values
and the previous reported toxic copper values may be related to the absence o f protein
from our medium. On the other hand, most o f the copper in the previous studies was in
the form o f complexes with protein.
4.3.2

Expected Mechanisms

Sperm toxicity may be related to many factors, however the most common one among
them was reactive oxygen species (ROS). Like all cells living under aerobic conditions,
spermatozoa produce ROS during normal metabolic activity. At the same time,
spermatozoa and seminal plasma contain a battery o f ROS scavengers, including many
enzymes such as superoxide dismutase (SOD), catalase and the glutathione (GSH)
peroxidase/reductase system (De Lamirande et al., 1997). The balance between ROS
generation and scavenging is very important. Excessive ROS generation that overcomes
the scavenging ability was found to be related to male infertility (Iwasaki and Gagnon,
1992). Although several studies demonstrated that high concentrations o f ROS induce
sperm pathology (ATP depletion leading to insufficient axonemal phosphorylation, lipid
peroxidation and loss o f motility and viability (Jones et al., 1979), low and controlled
concentrations o f ROS have an important role in sperm physiology (capacitation). This
means that fine balance between ROS production and scavenging is important for sperm
function and fertilization ability. Therefore, sperm motility reduction o f the tested
compound may be related to the increase o f ROS concentration (oxidative stress) in the
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culture medium. This may be directly through increasing ROS production (as in arsenic,
chromium and copper which produce oxyredicals) or indirectly through decreasing ROS
destruction through inhibiting scavenging enzymes (arsenic reduces cytosolic glutathione
level).
Mammalian spermatozoa are rich in polyunsaturated fatty acids and are thus very
susceptible to ROS attack. Such an attack results in decreased sperm motility,
presumably by a rapid loss o f intracellular ATP leading to axonemal damage and loss o f
viability in addition to the decreased motility. Lipid peroxidation o f sperm membranes is
considered to be the key mechanism o f this ROS-induced sperm damage (Alvarez et al.,
1987). Lipid peroxidation (LPO) is the most extensively studied manifestation o f oxygen
activation in biology. The most common types o f LPO are: (a) nonenzymatic membrane
LPO, and (b) enzymatic (NADPH and ADP dependent) LPO. The enzymatic reaction
involves NADPH-cytochrome P-450 reductase (Emster, 1993).
In general, the most significant effect o f LPO in all cells is the perturbation o f
membrane (cellular and organellar) structure and function (transport processes,
maintenance o f ion and metabolite gradients, receptor mediated signal transduction, etc.).
Besides membrane effects, LPO can damage DNA and proteins, either through oxidation
o f DNA bases (primarily guanine via lipid peroxyl or alkoxyl radicals) or through
covalent binding to malondialdehyde (MDA) resulting in strand breaks and cross-linking
(Emster, 1993). Sperm DNA is vulnerable to oxidative stress, in part because semen has
a weak antioxidant system (Zini et al., 1993) and in part because spermatozoa lack DNA
repair enzyme activity (Matsuda et al., 1989).
Hyperactivation in arsenic-treated sperm m ay be related to increased calcium
concentration at their axoneme. A number o f physiological factors, such as Ca2+, cAMP,
bicarbonate and metabolic substrate, are essential for initiation and maintenance o f
hyperactivated motility in vitro. It appeared that Ca2+ played a major role in regulating
hyperactivation. The cmcial site for the action o f Ca2+ is the axoneme. The increase in
the axoneme Ca2+ whether from extracellular or intracellular sources is required for
hyperactivation (Ho and Suarez, 2001). . A rise in intracellular calcium was elicited at
once after application o f AS2 O 3 to esophageal carcinoma cells (Shen et al., 2002).
Although, the mechanism o f how arsenic increases intracellular calcium levels was not
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clear, many explanations were given. One o f them, is that arsenic has been shown to
disrupt mitochondria and may elevate intracellular calcium via a signal transduction
pathway. Arsenite has also been reported to activate protein kinase C and mitogenactivated protein kinase. These kinases are known to be involved in the calcium signal
transduction pathway (Jun et al., 1999).
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CHAPTER V
CONCLUSIONS AND FUTURE WORK

5.1 Conclusions
Deterioration in embryonic and gamete development and quality in the presence o f
CCA ’s individual components (arsenic pentaoxide, chromium trioxide and cupric oxide)
and their mixtures was the hypothesis for this research.
The first aim was to determine the effect o f CCA (single, mixtures and synergismpotentiation) on embryo development. We found that embryonic exposure to arsenic,
chromium and copper concentrations o f even 0.5 mg/L, have a detrimental toxic effect on
embryo quality represented by significant reduction in total cell numbers although there
was no obvious reduction in embryonic developmental stages. Increasing concentration
above 0.5 mg/L was accompanied by a dose-dependant decrease in embryonic
development in the form o f drop in the number o f morula-blastocyst embryos and
elevation in ffagmented-degenerated embryos. TC 5 0 was determined to be at 0.7 mg/L
arsenic, 0.1-0.5 mg/L chromium and 0.1 mg/L copper. To determine the synergistic effect
o f CCA compound on embryo development, our findings indicated that combining these
individually-tested compounds, in m-CCA even in their nontoxic concentrations, produce
a synergistic embryotoxic effect. The only CCA mixture that did not show toxic effects
on embryo development and blastocyst formation rate was one-tenth the nontoxic
concentration o f each compound. However, most o f these blastocysts were
morphologically abnormal.
The second aim was to detect the developmental and genetic effect o f CCA
components on in vitro matured oocytes. Arsenic, chromium and copper were found to
induce spindle-chromosomal damage to mammalian oocytes that triggered meiotic arrest
at MI and affected checkpoint controls at low concentrations. These compounds become
potent meiotic arresters and fertility reducing chemicals at high concentrations. TC 5 0 is
0.7 mg/L arsenic, 0.1-0.5 mg/L chromium and 0.1 mg/L copper. The lack o f
chromosome-mediated checkpoint control imposed by the metaphase/anaphase
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checkpoint would be predicted to result in an elevated meiotic error rate in female
meiosis. In our own species, this is indeed the case. An estimated 20% o f human
conceptions are chromosomally abnormal and virtually all errors are maternal in origin
(Jacobs, 1992). This overstresses the toxicity o f CCA and its metal compounds.
Exposure to these metal compounds not only will affect oocyte maturation and reduce the
fertility but also may increase the teratogenicity if these abnormal M il oocytes succeed to
ovulate and be fertilized.
The third aim was to assess sperm function and viability in the presence o f CCA
components. The tested compounds not only have an inhibitory effect on sperm motility
but also have deleterious effects on sperm viability. TC^ q is 1-1.5 mg/L arsenic, 1.5
mg/L chromium and 0.5 mg/L copper. Almost all immotile sperm were non-viable even
at the lower tested concentration (0.5 mg/L) indicating that arsenic, chromium and copper
are very potent spermicidal.
We conclude that the presence o f arsenic, chromium or copper compounds in
embryo and gamete environmental medium have a severe detrimental effect on their
development and quality. Even though small amounts o f these metal compounds did not
show an obvious toxic effect on embryo and gamete development, greater reduction in
their quality and subcellular structure damage was observed. Consequently, it is
recommended to avoid any unnecessary exposure to arsenic, chromium and copper
compound.
The main contribution o f this study is that it may have a significant impact on
reproductive biology-toxicology o f gametes and embryos.

5.2 Future Work
The above study is one step toward detecting the behavior o f embryo and gametes
development and function in the presence o f individual components o f the CCA
compound. Like many research efforts, the doors are opened for further improvements
and extensions. In this section, we briefly explain some possible extensions to each
proposed experiments.
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5.2.1
•

Embryo Development

Total cell count o f blastocyst embryos was used in this study to detect the difference
in embryo quality between the treated and untreated embryos. As there was obvious
significant reduction in total cell numbers, differential staining o f inner cell mass and
trophectoderm cells can be used to allocate the reduction.

•

In addition, assessment o f blastomere viability using fluorescent markers o f cell
viability may help in ascertaining embryo viability.

•

To detect whether CCA toxicity on embryo development is mediated through
interfering on the mitotic spindle formation and embryonal cell division and / or
through affecting on mitochondrial function two tests can be performed:
■ Immunocytochemical staining methods may be used for labeling o f nuclei and
cytoskeleton o f preimplantation embryo.
■ Ratiometric confocal microscopy with the mitochondrion-specific membrane
potential-sensitive fluorescence dye JC-1 (5,5',6,6'-tetrachloro-l,l',3,3'tetraethylbenzimidazolyl-carbocyanine iodide) may be used to measure the
membrane potential and hence the activity o f mitochondria in preimplantation
embryos.

5.2.2
•

Oocyte Integrity

Although, chromosomal behavior o f treated oocytes used indirect antitubulin
immunofluorescence was accurate and efficient, chromosomal analysis using
combined fluorescence in-situ hybridization (FISH) with an X chromosome-specific
probe may localize the toxicity o f the tested compound.

•

Detecting the possibility o f the tested compounds to cause aneuploidy in the exposed
oocytes could be determined using C-banding.

•

Redundancy in cell cycle checkpoint especially at low tested compound
concentrations is a disastrous. Metaphase II treated oocytes that escaped the meiotic
arrest m ay either fail to ovulate (causing infertility) or develop to embryo if they were
fertilized (causing teratogenic effect). Correspondingly, detecting their ability to be
fertilized (through IVF) will be another topic for further research.
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•

By taking advantage o f Pol-Scope’s ability non-invasively to observe spindle and
chromosome structures in the living oocytes using polarized light, Pol-Scope m ay be
used for selection o f healthy looking treated oocytes before doing IVF.

5.2.3
•

Sperm Function

There is growing evidence that oxidative stress significantly impairs sperm function,
and plays a major role in the etiology o f defective sperm function. The measurement
o f the rate o f ROS generation by luminol-induced chemiluminescence has been the
most common method for quantifying ROS. Other methods that can be used for
measuring ROS can be categorized as:
■ Methods involving nitroblue tetrazolium (NBT) or cytochrome c-Fe+++
complexes that measure ROS on the cell membrane surface.
■ Methods that measure ROS (generated inside or outside the cell) utilizing
luminol-dependent chemiluminescence.

•

The electron spin resonance methods are more sensitive and can identify the type o f
ROS generated inside the cell. These methods are considered a new research direction
that needs further investigation.

•

Spermatozoa, unlike other cells, are unique in structure, function, and susceptibility to
damage by LPO. In spermatozoa, production o f malondialdehyde (MDA), an end
product o f LPO induced by ferrous ion promoters, is a simple and useful diagnostic
tool for the measurement o f LPO for in vitro systems.

•

Since any changes in mitochondrial function may be reflected in sperm motility,
evaluation o f mitochondrial function using JC-1 staining m ay be a useful tool to
assess the mechanism o f sperm toxicity.

5.2.4
•

Others

One o f the mechanisms o f substance toxicity is through reducing the cytosolic
glutathione level. GSH assay (Anderson, 1989), a colorimetric assay m ay be carried
out to quantify intracellular level o f GSH and determine the embryo and gamete
toxicity in the presence o f CCA.

•

Mitochondria are intracellular organelles, existing in eukaryotic cells, responsible for
production o f ATP, intracellular calcium regulation, and reactive oxygen species
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generation and are involved in apoptosis and cell death. These organelles are
extremely sensitive to minimal variations o f cellular physiology. Small changes in
pH, cellular oxygenation and the presence o f several substances may interfere in
mitochondrial respiratory metabolism. Arsenic, chromium and copper may be one o f
these substances. Based on that, mitochondrial respiration (measured
polarographically with a Clarktype oxygen electrode, Rodrigues et al., 2003) can be
used as a sensitive parameter to evaluate the biocompatibility o f arsenic, chromium
and copper exposed cells (embryos and gametes).
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APPENDIX A
RAW DATA FOR EMBYRONIC DEVELOPMENT

Table A .l. Analysis o f embryonic stage o f two-cell mouse embryos after 48 hr culture
in the presence o f arsenic
A S205

[mg/L]
Control
0 .1

0.3
0.5
0.7
0.9
1.1

1.3
1.5

cell

Embryo
number

2

30
30
30
30
30
30
30
30
30

(0 )
(0 )
0 (0 )
0 (0 )
0 (0 )
2(6.7)
3(10)
12 (40)
20 (66.7)
0
0

3-4 cell

5-8 cell

Morula

Blastocyst

FragmentedDegenerated

(0 )
(0 )
0 (0 )
0 (0 )
3(10)
4(13.4)
12 (40)
15 (50)
10 (33.4)

0

(0 )
1 (3.3)
0 (0 )
0 (0 )
7 (23.3)
5 (16.4)
5(16.7)
1 (3.3)
0 (0 )

6 (2 0 )
4(13.4)
4(13.4)
7 (23.3)
9(30)
15 (50)
7 (23.3)
0 (0 )
0 (0 )

24 (80)
24 (80)
25 (0)
23 (76.7)
10 (33.4)
4 (13.4)
2 (6.7)
1 (3.3)
0 (0 )

0

0
0

(0 )
1 (3.3)
1 (3.3)
0 (0 )
1 (3.3)
0 (0 )
1 (3.3)
1 (3.3)
0 (0 )

Table A.2. Analysis o f embryonic stage o f two-cell mouse embryos after 72 hr culture
in the presence o f arsenic
A.S2O5
[mg/L]

Embryo
number

2

cell

3-4 cell

Control

30
30
30
30
30
30
30
30
30

0

(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )

0

0 .1

0.3
0.5
0.7
0.9
1 .1

1.3
1.5

0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0

(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )

5-8 cell

Morula

Blastocyst

FragmentedDegenerated

(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )

(0 )
0 (0 )
1 (3.3)
2(6.7)
0 (0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )

30 (100)
28 (93.3)
29 (96.7)
28 (93.3)
19 (63.3)
19 (63.3)
11 (36.7)
2(6.7)
0 (0 )

0 (0 )
2 (6.7)
0 (0 )
0 (0 )
11 (36.7)
11 (36.7)
19(63.3)
28 (93.3)
30 (100)

0
0
0
0
0
0
0
0
0

0
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Table A.3. Analysis o f embryonic stage o f two-cell mouse embryos after 48 hr culture
in the presence o f chromium
3-4 cell

5-8 cell

Morula

Blastocyst

FragmentedDegenerated

1 (2 )

1 (2 )
0

37 (74)
7(70)
15 (83.3)
13(61.9)
14 (77.8)
19 (86.4)
18(85.7)
21(84)
13 (76.5)
24 (70.6)
11 (64.7)
4 (66.7)
4(40)
1 (14.3)
0 (0 )

5(10)
3 (30)
0 (0 )
2(9.5)
0 (0 )
2(9.1)
2(9.5)
2 (8 )
1 (5.9)
2(5.9)
0 (0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )

6

(0 )
(0 )
1 (4.8)
0 (0 )
1 (4.5)
0 (0 )
0 (0 )
1 (5.9)
0 (0 )
0 (0 )
0 (0 )
2 (2 0 )
0 (0 )
1 ( 1 1 .1 )

(0 )
0 (0 )
2 ( 1 1 .1 )
2(9.5)
0 (0 )
0 (0 )
1 (4.8)
1(4)
0 (0 )
1 (2.9)
1 (5.9)
0 (0 )
2 (2 0 )
0 (0 )
6 (66.7)

C r0 3
[mg/L]

Embryo
number

2

Control

50

0 .1

10

0

0 .2

18

0

0.3
0.5
0.7
0.9

21

1 .1

25
17
34
17

1.2
1.5
1.7
1.9

18
22
21

6

2 .0

10

2.5
3.0

7
9

cell

(0 )
1 (5.6)
2(9.5)
2 ( 1 1 .1 )
0 (0 )
0 (0 )
1(4)
2 ( 1 1 .8 )
6(17.6)
5 (29.4)
2 (33.3)
2 (2 0 )
4(57.1)
1 ( 1 1 .1 )

0

(12)
0 (0 )
0 (0 )
1 (4.8)
2 ( 1 1 .1)
0 (0 )
0 (0 )
0 (0 )
0 (0 )
1 (2.9)
0 (0 )
0 (0 )
0 (0 )
2 (28.6)
1 ( 1 1 .1)

T able A.4. Analysis o f embryonic stage o f two-cell mouse embryos after 72 hr culture
in the presence o f chromium
C r0 3
[mg/L]

Embryo
number

Control

50

1 (2 )

1 (2 )

0 .1

10

(0 )
0 (0 )
1 (4.8)
0 (0 )
1 (4.5)
0 (0 )
0 (0 )
1 (5.9)
1 (2.9)
0 (0 )
0 (0 )
2 (2 0 )
0 (0 )
1 ( 1 1 .1)

0

(0 )
1 (5.6)
2(9.5)
0 (0 )
0 (0 )
0 (0 )
1(4)
2 ( 1 1 .8 )
5 (14.7)
0 (0 )
0 (0 )
3 (30)
4(57.1)
1 ( 1 1 .1 )

0 .2

18

0.3
0.5
0.7
0.9

21

1 .0
1.1

1.5
1.7
1.9

18
22
21

25
17
34
17
6

2 .0

10

2.5
3.0

7
9

2

0

cell

3-4 cell

5-8 cell

Morula

Blastocyst

FragmentedDegenerated

0

(0 )
(0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )
3 (8 .8 )
3 (17.6)
1 (16.7)
0 (0 )
0 (0 )
1 ( 1 1 .1)

1 (2 )

0

(10)
0 (0 )
2(9.5)
2 ( 1 1 . 1)
0 (0 )
0 (0 )
1(4)
1 (5.9)
2(5.9)
4 (23.5)
1 (16.7)
1 (1 0 )
0 (0 )
0 (0 )

40 (80)
9(90)
17(94.4)
15(71.4)
14 (77.8)
21 (95.5)
2 1 (100)
23 (92)
13 (76.5)
22 (64.7)
8(47.1)
3 (50)
0 (0 )
1 (14.3)
0 (0 )

7(14)
(0 )
0 (0 )
1 (4.8)
2 ( 1 1 . 1)
0 (0 )
0 (0 )
0 (0 )
0 (0 )
1 (2.9)
2 ( 1 1 .8 )
1 (16.7)
4(40)
2 (28.6)
6 (66.7)

1
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Table A.5. Analysis o f embryonic stage o f two-cell mouse embryos after 48 hr culture
in the presence o f copper
CuO
[mg/L]

Embryo
number

2

Control

28

0

0 .1

11

0

1 .0

5.0

16
30

6 .0

20

7.0

22

8 .0

19

9.0

21

1 0 .0

10

cell

(0 )
(0 )
0 (0 )
0 (0 )
0 (0 )
2(9.1)
6(31.6)
5 (23.8)
2 (2 0 )

3-4 cell

(0 )
1 (9.1)
2(12.5)
0 (0 )
0 (0 )
16 (72.7)
13 (68.4)
9 (42.9)
1 (1 0 )
0

5-8 cell

Morula

Blastocyst FragmentedDegenerated

(0 )
(0 )
0 (0 )
0 (0 )
0 (0 )
1 (4.6)
0 (0 )
0 (0 )
0 (0 )

17 (60.7)
1 (9.1)
2(12.5)
29 (96.7)
18(90)
3 (13.6)
0 (0 )
0 (0 )
0 (0 )

10 (35.7)
9(81.8)
12 (75)
0 (0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )
0 (0 )

0
0

1 (3.6)
(0 )
0 (0 )
1(3.3)
2 (1 0 )
0 (0 )
0 (0 )
7 (33.3)
7(70)
0

T able A.6. Analysis o f embryonic stage o f two-cell mouse embryos after 72 hr culture
in the presence o f copper
CuO
[mg/L]

Embryo
number

2

(0 )
(0 )
0 (0 )
0 (0 )
0 (0 )
1 (4.6)
2(10.5)
0 (0 )
0 (0 )

Control

28

0 .1

11

1 .0

5.0

16
30

6 .0

20

7.0

22

8 .0

19

9.0

21

1 0 .0

10

0

0

cell

3-4 cell

(0 )
1(9.1)
0 (0 )
0 (0 )
0 (0 )
10 (45.5)
0 (0 )
0 (0 )
0 (0 )
0

5-8 cell

Morula

Blastocyst

FragmentedDegenerated

(0 )
(0 )
(6 .2 )
(0 )
(0 )
(0 )
(0 )
(0 )
(0 )

2(7.1)
(0 )
0 (0 )
1 (3.3)
3(15)
1 (4.6)
0 (0 )
0 (0 )
0 (0 )

24 (85.7)
10(90.1)
15 (93.8)
28 (93.3)
14 (70)
2(9.1)
0 (0 )
0 (0 )
0 (0 )

2(7.1)
0 (0 )
0 (0 )
1 (3.3)
3(15)
8 (36.4)
17 (89.5)
21 (100)
10 (1 0 0 )

0
0
1
0
0
0
0
0
0

0
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Table A.7. Analysis o f embryonic stage o f two-cell mouse embryos after 48 hr culture
in the presence o f CCA mixture
CCA
[mg/L]

Embryo
number

2 cell

3-4 cell

5-8 cell

Morula

Blastocyst

FragmentedDegenerated

Control
m-CCAl
m-CCA2
m-CCA3
m-CCA4
m-CCA5

50
82
41
43
41
41

3(6)
4 (4.9)
7(17.1)
2(4.7)
7(17.1)
0(0)

0(0)
44 (53.7)
18(43.9)
16 (37.2)
4 (9.8)
0(0)

2(4)
18(21.9)
6 (14.6)
6(13.9)
0(0)
0(0)

43 (86)
16(19.5)
2(4.9)
19 (44.2)
30 (73.1)
1 (2.4)

0(0)
0(0)
0(0)
0(0)
0(0)
39 (95.2)

2(4)
0(0)
8 (19.5)
0(0)
0(0)
1 (2.4)

The m-CCAi is a chromated copper arsenate mixture arranged from highest to lowest concentration.

Table A.8. Analysis o f embryonic stage o f two-cell mouse embryos after 72 hr culture
in the presence o f CCA mixture
CCA
[mg/L]

Embryo
number

2 cell

3-4 cell

5-8 cell

Morula

Blastocyst

FragmentedDegenerated

Control
m-CCAl
m-CCA2
m-CCA3
m-CCA4
m-CCA5

50
82
41
43
41
41

0(0)
0(0)
0(0)
2(4.7)
0(0)
0(0)

0(0)
7 (8.5)
3 (7.3)
2(4.7)
0(0)
0(0)

0(0)
3 (3.7)
3 (7.3)
0(0)
1 (2.4)
0(0)

0(0)
4 (4.9)
0(0)
2(4.7)
4 (9.8)
0(0)

45 (90)
0(0)
2 (4.9)
4(9.3)
8(19.5)
40 (97.6)

5(10)
68 (82.9)
33 (80.5)
33 (76.7)
28 (68.3)
1 (2.4)

The m-CCAi is a chromated copper arsenate mixture arranged from highest to lowest concentration.
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